Skip to content

Advertisement

  • Review
  • Open Access

Distinct role of autophagy on angiogenesis: highlights on the effect of autophagy in endothelial lineage and progenitor cells

Contributed equally
Stem Cell Research & Therapy20189:305

https://doi.org/10.1186/s13287-018-1060-5

  • Published:

Abstract

Autophagy plays a critical role in the dynamic growth of each cell through different conditions. It seems that this intracellular mechanism acts as a two-edged sword against the numerous cell insults. Previously, autophagy was described in the context of cell activity and behavior, but little knowledge exists related to the role of autophagy in endothelial cells, progenitors, and stem cells biology from different tissues. Angiogenic behavior of endothelial lineage and various stem cells are touted as an inevitable feature in the restoration of different damaged tissues and organs. This capacity was found to be dictated by autophagy signaling pathway. This review article highlights the fundamental role of cell autophagic response in endothelial cells function, stem cells dynamic, and differentiation rate. It seems that elucidation of the mechanisms related to pro- and/or anti-angiogenic potential of autophagy inside endothelial cells and stem cells could help us to modulate stem cell therapeutic feature post-transplantation.

Keywords

  • Stem cell
  • Autophagy
  • Angiogenesis
  • Differentiation
  • Functional maturation

Terms and definition

In addition to synthesis, protein degradation is an important mechanism for the physiologic activity of each cell inside the body. Cells commonly exploit two main strategies to degrade intracellular proteins, namely a ubiquitin-proteasome system and autophagy [1]. Autophagy is apparently a crucial and tight regulated normal catabolic process for cell survival during growth, starvation, and differentiation and even plays fundamental biological roles in various cellular functions [1]. In scientific literature, autophagy is defined as sequestration of misfolded, impaired, and toxic aggregate-prone mutant proteins, whole damaged and dysfunctional organelles, or intracellular pathogens into double-membrane autophagic vesicles termed autophagosomes that finally merge with lysosome for degradation (autophagolysosome) [2]. Regarding delivery pathway of the biomolecules to the lysosomes, three distinct types of autophagy mechanisms were previously discovered: (a) Macroautophagy that surrounds the material with a dual lipid membrane, named autophagosome and then fuses with lysosomes finally formed autophagolysosome; (b) microautophagy, which directly enters substances into the lysosomes through the intrusion of self-membrane (Fig. 1); and (c) CMA that is degradation of a proteins with specific motifs (KFERQ) targeted by HSC70 complex and then adhere to lysosome via LAMP2A (Fig. 1). Other aliases exist regarding autophagy such as aggrephagy, mitophagy, lipophagy, and xenophagy depending on which substance is sequestrated and digested [3, 4]. In this review, macroautophagy will be termed as autophagy. Autophagy is a general response to a diversity of external and internal stress stimuli. Under these conditions, autophagy is stimulated via signaling the mechanisms that ordinarily involve activation of the AMPK and inhibition of mTOR [5]. The process of autophagolysosome formation involves initiation, elongation, and maturation stages and the following merge of the autophagosome with lysosomes to form an autophagolysosome [2]. Autophagy is initiated by a membrane nucleation that requires the ULK1 complex with FIP200, Atg13, Atg9, a regulatory class III PI3K complex that includes Beclin-1, known as Atg6, and Atg5-Atg12-Atg16 multimerization complex [6] (Fig. 1). Under physiological conditions, mTOR prevents autophagy by the phosphorylation and inhibition of Atg13 activity that inhibits its interaction with ULK1. mTOR also prevents ULK1 activity by phosphorylation of ULK1 and disrupting the interaction between ULK1 and AMPK [7]. In the absence of these inhibitory signals, Atg13 and ULK1 interact with Atg17 and the ULK1-Atg13-Atg17 complex to initiate autophagosome formation. Recruitment of Atg9 to the ULK1-Atg13 complex is a key step for the primary lipidation of pre-autophagosomal structure membrane [8]. The next steps are regulated by a complex of Beclin-1 with PI3K-III and Atg14 [9]. As soon as autophagy is stimulated by starvation and hypoxia, Atg14 (the pre-autophagosome protein) accumulates at the endoplasmic reticulum-mitochondrion contact surface in a SNARE, syntaxin 17-dependent manner [10]. Atg14 connects PI3K molecules to Beclin-1 and results in the development of a complex on the pre-autophagosomal structure [10]. Afterward, many of the Atg proteins will focus on the pre-autophagosomal structure; therefore, the pre-autophagosomal structure is considered to be linked to the formation of the autophagosomes [11]. Moreover, Beclin-1 is released from Bcl-2 and forms a complex with the ultraviolet radiation resistant gene/activating molecule in Beclin 1-regulated autophagy [12]. This complex starts conjugation of Atg12 to the substrate Atg5 by Atg7 and Atg10 to form an Atg5-Atg12-Atg16 multimeric complex [13]. Atg4 converts LC3 from LC3β-I, free-form, to LC3β-II, in phosphatidylethanolamine-conjugated form, that regarded as a crucial step in autophagosome formation. The LC3β-II is conjugated via phosphatidylethanolamine irregularly on both sides of the membrane by Atg9 within the ULK complex [14]. This process will more continue until the end of the autophagosome formation. So, LC3β-II is released from the external surface of the membrane. Then, from this conception, it can be concluded that LC3β-II can serve as an analytical marker for monitoring autophagic flux [15]. The newly formed autophagosome together with the cargo to be degraded finally merge with lysosomes to form an autolysosome that their content is lysed by lysosomal enzymes [2]. By transferring the autophagosomes to lysosomal proximity, microtubules regulate and facilitate the fusion of autophagosomes with lysosomes. Then, LAMP1/2, lysosomal membrane proteins, Rab7 (member of Rab GTPases family), SNARE, class III Vps, and endosomal sorting complexes are required for transport which mediates the process of fusion [16, 17]. Finally, the formation of the autolysosome provides an acidic environment that is essential for the ideal activity of lysosomal hydrolases, cathepsins and cargo degradation [18]. Amid autophagy factors, p62 is degraded along with the targeted proteins and organelles, while LC3 may be degraded or recycled back into the cytosol pool [19]. It is noteworthy to conclude that the pattern of autophagy proteins reveals the state and progression of autophagy. Activation of autophagy contributes to the accumulation of LC3-bound, increased LC3-II/I ratio, and reduction of p62 levels, reflecting degradation in the autolysosomes [20]. The defect of autophagy at the beginning stage is characterized by a decreased LC-3-bound, loss of LC3-II, and raised p62 levels inside cells [2123]. Failure of the final phases of autophagy, autophagosome-lysosome fusion or cargo degradation, is characterized by a normal or increased number of LC-3-bound, increased LC3-II and p62 in the cell that revealed a failure to clear autophagosomes and degrade p62 (Fig. 1) [22].
Fig. 1
Fig. 1

Autophagy is classified into three types based on the route of delivery. Microautophagy refers to the sequestration of misfunction proteins or whole organelles such as mitochondria (named mitophagy) directly by lysosomes. Chaperone-mediated autophagy (CMA) involves direct translocation of misfolded substrates across the lysosome membrane through the action of a cytosolic and lysosomal chaperone hsc70, and the integral membrane receptor LAMP-2A (lysosome-associated membrane protein type 2A). In the case of macroautophagy, the cargoes are sequestered within a unique double-membrane cytosolic vesicle, named autophagosome. This type of autophagy is initiated by the nucleation of an isolation membrane or phagophore. ULK, ATG 13, FIP200, and ATG101 are involved in this stage. Then, the Beclin-1 and ATG14L complex contributes to the nucleation of the phagophore. This membrane then elongates and closes on itself to form an autophagosome. Elongation of the phagophore membrane is dependent on the Atg12 and LC3 conjugation systems. Closure of the autophagosome is dependent on the activity of the LC3-conjugation system. The autophagosome matures by fusing with endosomes and lysosomes, finally forming the autophagolysosome where the cargo degradation occurs

Effect of autophagy on various SC differentiation

Despite distinct features of self-renewal, differentiation, multi-potency, and quiescence status in different organs, SCs should improve the restorative potency of organelles turnover [24]. In this regard, autophagy as a well-known quality control process is essential for the high maintenance of SCs homeostasis [25]. Based on their origin, SCs could be classified into two types and one of them is ESCs that is originated from inner cell mass of murine and human blastocytes and the second one is ASCs seen isolated from adult tissues. Compare to ESCs, ASCs, but not all types such as intestine crypt stem cells, pose a limited stemness feature which is localized in specific mature sites to repair tissues in response to certain diseases [26, 27]. Maintenance of balance between stemness and differentiation in SCs is a very important issue [28]. An excessive differentiation rate may lead to cell aging, while untamed cell proliferation can raise the emergence of cancer cells formation [29]. Growing body of evidence revealed that autophagy modulates differentiation in both ESCs and ASCs [30]. It seems that autophagy is one of the indirect metabolic pathways that can be modulated in both ESCs and ASCs. Thus, we briefly scoped the crucial role of autophagy response in the maintenance of stemness and differentiation of various SC types. Commensurate with these descriptions, autophagy response and related signaling pathways have potential to direct and inspire distinct phenotype and cell function in SCs in the favor of regeneration or reduce restorative capacity.

Role of autophagy on ESCs

Autophagy has an essential role during cell reprogramming and embryogenesis period [31]. Autophagy response is commonly upregulated at an early stage of human and murine SC differentiation [32]. In line with this statement, some pharmacologic agents are used for deciphering autophagy effects on the differentiation capacity of SCs [33, 34]. HMBOX1, known as a transcription repressor, has the ability to regulate autophagy [35]. Inhibition of HMBOX1 could per se inhibit the autophagy while the promotion of this factor stimulates autophagy flux [35]. It has been reported that during MSC and ESC differentiation into endothelial-like cells, the stimulation of HMBOX1 coincided with the induction of autophagic response [35]. It has been elucidated that HMBOX1 potentially interacts with MT2A to initiate autophagy while inhibiting apoptosis in vascular ECs [35]. Under treatment with autophagy inducer such as rapamycin ESCs transition into osteoblast cells was promoted by the inhibition of mTOR and promotion of BMP/Smad signaling pathway [36]. Autophagy also increased human ESCs’ survival by SIRT-1 activation and subsequent mTOR inhibition against oxidative stress-induced damages [37]. The factor SIRT1 was found to stimulate autophagy-related signaling pathway and improve mitochondria function in ECs under oxidative stress. There is a close relation with autophagy and cytokines participating in stemness acquisition [38, 39]. For instance, it was reported that LIF is required to preserve the multi-potency of murine ESCs [38, 39]. In vitro depletion of LIF from medium has the potential to trigger mTOR signaling pathway through the modulation of ERK/Tuberin axis [40]. LIF depletion also contributes to the activation of MEK/ERK/TSC2 transition from the LIF/STAT3-induced pluripotent state to the fibroblast growth factor receptor 2/ERK-committed differentiation governed by mTOR signaling activation [39]. In an experiment, it was shown that Atg3+/−, Atg3−/−, and FOXO-1−/− murine ESCs lost the potency of self-renewal and differentiation capacity [41]. The high autophagic flux rate ensures ESC entity through engaging autophagy machinery effector termed FOXO-1. This factor acts a pivotal role in the regulation of SOX2 and OCT4 (POU5F1) expression [41, 42]. There is an inevitable correlation between FOXO-1 level and the expression of autophagy-related genes. The deficiency of autophagy genes such as Atg5 and Beclin-1 has long been reported ESCs during embryogenesis and fetal development [43]. Both genes participate in SC cavitation during the formation of the embryoid body [43]. Even, modulating autophagy under insulting condition could have some beneficial outcomes regarding SC orientation toward specific phenotypes.

During starvation, the induction of autophagy via the treatment of rapamycin could induce morphological changes by degrading the midbody ring prior to cell-to-cell separation [44]. By using Atg5-null oocytes and sperms, the generation of the blastocyst and therefore inner cell mass was stopped [45]. Commensurate with these comments, the ablation of Beclin-1 gene leads to early embryonic lethality in murine ESCs [46]. Some compensatory mechanism could be activated in autophagy-deficient conditions. For example, the ubiquitin-proteasome system degrades the damaged organelles and unfolds proteins in response to autophagy insufficiency [47]. This reciprocal crosstalk between the ubiquitin-proteasome system and autophagy signaling has been documented in human autophagy-deficient ESCs. To further follow autophagic state on cell differentiation capacity during early embryogenesis, HESC-GFP-LC3 cell line was established based on the expression of the green fluorescent protein encoded with some pluripotency markers [48]. Ambra1 deficiency, as a positive regulator of autophagy, may cause embryonic lethality and lack of Ambra1 function, increased apoptotic changes and predisposed nervous system insufficiency [49]. Overall, autophagy is an essential element for an early embryogenesis and differentiation during the development of the embryo. By controlling the effectors through autophagy signaling pathway, we are able to modulate the differentiation and orientation of distinct SCs toward specific lineages.

Role of autophagy on HSCs

There are a plethora of experiments implicating the role of autophagy on the dynamic hemostasis of HSCs. HSCs can differentiate to blood progenitor cells and restore all blood cell types. In the absence of autophagy, differentiation of HSCs into mature lineages was disrupted and the possibility of malignancies would increase [50]. For instance, in null Atg5−/− mice, an increased cell apoptosis in cytotoxic CD8+ T cells was observed with the occurrence of lymphopenia [51]. Other authors demonstrated that mutation of another autophagy member Atg7 in hematopoietic system yielded an impaired mitophagy by enhancing of ROS generation, oxidative stress and DNA damage in erythrocytes with subsequent anemia and defective self-renewal [50]. The application of siRNAs targeting Atg 5 and Atg 7 fails to generate colony formation in HSCs in vitro [32]. These results show that autophagy mainly preserves self-renewal and multipotency of HSCs in human or murine models [32]. The factor LKB1, a Serine/threonine-protein kinase tumor suppressor, has an indispensable role in maintaining energy hemostasis [52]. Lack of LKB1 in mouse HSC leads to cell cytotoxicity and accumulation of LC3-II in the bone marrow, spleen, and thymus [53]. Recent studies confirmed that the modulation of miRNAs, miR-17, − 20, − 93, and − 106 have the potency to regulate the dynamic growth of HSCs through the downregulation of gene p62 [54]. P62, an adaptor protein, plays a key role in proteasomal and autophagy degradation pathway [55]. Based on the data from recent studies, autophagy role was shown in the last stages of HSC differentiation [54]. Some factors could control the activity of autophagy-related genes [56]. For instance, GATA1 as a crucial regulator of the hematopoietic system could also control MAP1LC3B as well as lysosomal biogenesis factors [56]. Recent findings declared that transcription of autophagy-related genes was enhanced during fetal HSC differentiation in murine embryo indicated by single-cell RNA sequencing technique [57]. In Tie2+ HSCs, mitophagy was found to have an essential role in impaired mitochondria clearance and the maintenance of stemness feature of murine HSCs [58]. By inducing PINK1 and PRKN genes, two key regulators of mitophagy, the differentiation property of HSCs was confirmed in high levels [58]. Deletion of PINK1 and PRKN genes caused a failure in the regeneration and renewal activity of HSCs. Regarding these comments, it is noteworthy that autophagy is an essential element for stable quiescence in HSCs [59]. This finding strongly supports a notion that autophagy not only has a pivotal role in multipotency and remodeling of HSCs under physiologic condition but also preserves stemness of HSCs by decreasing oxidative stress [60]. Interestingly, autophagy activity is touted as an important mechanism to suppress HSCs metabolism and preserve stemness with aging [61]. The regulation of basal cell metabolism and function of young and old SCs is done via engaging autophagy-related effectors [61]. A factor titled FOXO3 activates a Bcl-2 interacting mediator of cell death and promotes mitochondrial depolarization and subsequent ROS generation. The activation of FOXO3 could prohibit ROS production by survivin activation and BCL-XL inhibition. Notably, FOXO3A regulates a pro-autophagy gene expression status to maintain HSCs by autophagic responses following the occurrence of metabolic stress [62]. Mutant Beclin-1+/− or Atg5−/− HSCs trigger the upregulation of Bcl-2 expression, causing genomic instability, aneuploidy, and DNA and chromosomal damages [63]. A protective effect of autophagy on HSC genomic integrity and reconstitution capacity was indicated in irradiated mice [64].

Role of autophagy on NSCs

Evidence point NSCs could proliferate and differentiate into other types of neural lineages. For the first time, the effect of autophagy was investigated on in vitro model of murine neuroblastoma cell line N2a cells [65]. Similar to other stem cell types, the critical role of FOXO1, FOXO3, and FOXO4 have been documented on the dynamics of murine NSCs. For instance, in FOXO1, FOXO3, and FOXO4 null mice, oxidative stress and uncontrolled ROS production abrogated NSCs’ proliferation and inhibited the NSC differentiation potential [66]. Atg9a high expression rate (synaptic proteins) induced by miR-34a downregulation was shown to affect the murine NSC differentiation feature [67]. Another study confirmed that deletion of ULK-interacting protein FIP200 required for autophagosomes increased ROS content and superoxide level during p62 aggregation. These features promoted NSCs cell death through p53-dependent apoptosis pathway and cell cycle arrest [68]. Under in vivo condition, FIP200 is also required for NSC differentiation in the sub-ventricular zone of neonatal mice by the simultaneous limitation of microglia activity [69]. Suppression of SIRT1, a member of the sirtuin family, also could impress the NSC differentiation as well [70]. The expression of MiR-34a reduced SIRT1 expression and enhanced NSCs maturation rate and differentiation potential [71]. These findings support the notion that autophagy has a crucial role in NSC differentiation. A large number of experiments proposed the role of autophagy on embryonic and adult neural stem cells. According to recent findings, the expression of MapLC3a, Belcin-1, Atg7, and Ambra1 were significantly increased in in vitro model of murine olfactory bulb-derived NSCs [72]. In Ambra1 knockout mice, neural differentiation was abrogated and followed by neural tube defects during embryogenesis [49]. By suppressing Atg5 in the murine cerebrocortical region, the defective neurogenesis was observed [73]. Chemical induction of SC differentiation promoted the increased GFP-LC3 punctae and genetic/chemical inhibition of autophagy caused defective differentiation in N2a cells [65]. In the autophagy-related pathway, the role of lysosome in degradation is not indispensable. Then, lysosomal dysfunction leads to neural or non-neural death because of extra-accumulation of autophagosomes [74]. It has been posted in an experiment that the deletion of gene Atg7 could also amplify the neural cell death caused by chemical inhibition of autophagy at a late stage [75]. Ataxia telangiectasia mutated protein kinase has a key role in response to DNA damages and impaired genomic integrity. In Ataxia telangiectasia-mutated protein kinase-deficient NSCs, oxidative stress and ROS accumulation appeared by p38-MAPK activation and p16 induction [76, 77]. Considering dual roles of autophagy on cell dynamic, recent findings proposed that the infection of human fetal NSCs by Zika virus via NS4a A and NS4B (two important Zika proteins) inhibits Akt-mTOR signaling and induces abrupt autophagy, leading to defective neurogenesis and cell death [78]. Consistent with such an idea, autophagy also serves as a quality control mechanism in the hippocampal region by preserving stemness and neurogenesis rate. Also, autophagy has the potential to eliminate defective NSCs following insulin withdrawal by type 3 ryanodine receptor-mediated endoplasmic reticulum Ca2+ regulation of autophagy and programmed cell death in NSCs [79, 80].

Role of autophagy on MSCs

MSCs are pluripotent SCs that can differentiate into a variety of cell types including osteoblasts, chondrocytes, fibroblasts, adipocytes, and ECs. During differentiation to various cell lines, some factors are required for the osteogenic-adipogenic switch. For example, culturing density, cell shape, stimulatory growth factors, structural properties, and the levels of Rho GTPase (Rho-A) activity seems to be important [81, 82]. Although there is a little knowledge about autophagy role on MSCs, some studies demonstrated that autophagy has an essential role in oriented differentiation of MSCs and touted as a therapeutic value especially in regenerative medicine. The more recent experiment confirmed that autophagy induction sustains MSCs survival rate and promotes MSCs proliferation and differentiation into neural-like cells by increasing neuron-specific enolase and microtubule-associated protein 2 expression [83]. In pre-adipocytes, Atg7 and Atg5 mutations caused the reduction of adipose mass and differentiation, and an enhanced insulin sensitivity of Beclin-1 promoted differentiated chondrocytes cell death [84]. Autophagy also could protect mesenchyme-derived chondrocytes during the occurrence of osteoarthritis through engaging ULK1, BECN1, and MAP1LC3A [85]. Likewise, constitutive autophagy response plays an essential role in osteocytes hemostasis. Silencing the RB1CC1/FIP200 complex genes, essential for autophagosome formation, caused disruption of osteogenesis in osteoblasts in vitro and in vivo models [86]. Moreover, autophagy participates in osteogenic differentiation of human dental pulp derived-MScs time-dependently through mTOR inhibition-mediated autophagy and late activation of Akt/mTOR signaling pathways [87]. It is important to note that competent autophagy activity is limited to undifferentiated MSCs. Recent data showed that the level of GFP-LC3 puncta in primary murine bone marrow stromal cells isolated from GFP-LC3 transgenic mice is significantly low after differentiation into osteoblast cells [86]. Moreover, the authors demonstrated that autophagy induction protected primary and cell line MSCs from apoptotic cell death under the hypoxic condition and serum deprivation by releasing anti-apoptotic or pro-survival factors [88, 89]. Contradictory findings revealed the modulatory effect of autophagy in MSC-based cell therapy. In better words, the suppression of autophagy could accelerate the liver regeneration in the in vivo model of acute liver failure [90]. Interestingly, the quality control of autophagy plays an indispensable role in neurodegenerative diseases such as Alzheimer and Parkinson. Vice versa, a recent finding demonstrated the interactive role of MSCs against autophagy machinery system. In fact, MSCs enhance autophagic activity and subsequently β-amyloid clearance in Alzheimer’s disease [91]. SIRT1 protein as one of the key modulator of autophagy machinery influences the MSC differentiation. SIRT1 can promote the mesangial cell proliferation under high glucose condition and restrict expression of aged MSCs phenotypes. Mutation of miR-195 in aged MSCs enhanced SIRT1 function and anti-age relating factors including FOXO1, Akt, and telomerase reverse transcriptase [38, 92, 93].

Role of autophagy on MPCs and CPCs

The skeletal muscles are polynucleated syncytial cells which composed of myofibers and carry out the growth and the repair of muscle cells. The existence of MPCs known as satellite cells plays a crucial on muscle restoration [94]. During muscle development, embryonic myoblasts differentiate to adult myofibers and constitute the mature muscles. These myofibers are responsible for the further development of neonatal myogenesis [94]. Satellite cells are entirely quiescence while after muscle damage fused to damaged muscles and stimulate the muscle proliferation and differentiation. The effect of autophagy on MPCs just has been investigated recently. García-Prat and co-workers showed that the population of murine satellite cells, in Atg-7 (−/−) mutant cells notably reduced [95]. In agreement with this finding, in aged satellite cells, a similar phenotype of Atg7-deficient cells was observed coincided with enhanced senescence markers such as p16INK4a, P15INK4b, p21CIP1, and increased oxidative stress. Additionally, DNA damage and p62 aggregation were imitated. Moreover, reduction of autophagic flux was detected in satellite cells isolated from aged mice [96, 97]. Autophagy regulates satellite cells’ bioenergetics feature during cell function and circadian recycling of cell damaged ingredients and organelles [98, 99]. CPCs have the ability to differentiate into ECs and smooth muscle cells besides cardiomyocytes. Suppression of FGF signaling axis is required for CPC differentiation capacity [100]. By activating FGF receptors, autophagy machinery was inhibited by the engaging Akt-MAPK pathway. On the other hand, the induction of autophagy, in turn, blocks FGF receptors and promotes the CPC differentiation. Due to the role of autophagy on maintenance of CPCs survival, autophagy induction is one of the most important strategies besides the SCs derived exosomes and expression of miRNAs in SC therapy of ischemic myocardium [101].

Role of autophagy on CSCs

Recently, most of the studies focused on autophagy role in cancer stem cell characteristics [102, 103]. In a comparison of other stem/progenitor cells, CSCs have a similar self-renewal property but a higher level of basal autophagy activity especially under hypoxic niche beside of metastasis potency and resistance against chemotherapy [104, 105]. Considering the dual role of autophagy in either tumor-suppressing or tumor-promotion, autophagy effect on CSCs strongly correlates with cancer type and the stage of tumor development [106]. In the case of tumor suppression, the contradictory data implicated that mutation of the PTEN gene emerged during malignant differentiation of SCs while PTEN downregulation is associated with repopulation and tumorgenesis capacity of CSCs [107109]. The high content of PTEN promotes autophagy induction and limits the CSC activity. In contrast, autophagy inhibition by the silencing of BECN1 and ATG7 genes was found to abrogate the self-renewal of breast cancer cells both in vivo and in vitro models [110, 111]. In an experiment, it was unveiled that FIP200, as a very important regulator of autophagy, reduced the tumor-propagating of both aldehyde dehydrogenase 1 positive and CD29hiCD61+ breast CSCs through suppressing the EGFR/Stat3 and TGF-β/Smad axis [83]. Moreover, loss of autophagy reduced survival rates of chronic myeloid leukemia CD34+ progenitor cells while promoting the acute myeloid leukemia progenitor cells proliferation [103]. Yang and co-workers also showed a similar trend. It was shown a pro-survival activity in colorectal CSCs relied on oxaliplatin-induced autophagy that participates in the maintenance of stemness and chemo-resistance [112]. A study also implicated that pharmacological blocking of factor Notch leads to autophagy activity and subsequent drug resistance in glioma neurospheres [113]. Taken together, more studies are required for establishing the impacts of autophagy function as a potential therapeutic target of CSCs.

The correlation between autophagy and angiogenesis

Angiogenesis is a crucial phenomenon for maintaining blood nourishment under the normal condition that also participates in the regeneration of ischemic cardiac tissue or impaired peripheral vascular [114, 115]. In contrast, the tumor progression and metastasis could be enhanced by promoting angiogenesis under pathological conditions [116]. This phenomenon could participate in the healing of different organs and respond to the demands of tissues and organs under pathological and physiological conditions [117]. It seems that the angiogenesis potential of SCs has a critical role to accelerate restoration of injured tissues which is governed via cell differentiation into endothelial lineage and releasing different pro-angiogenic factors via paracrine manner [118]. It has been elucidated that angiogenic activity of SCs could be controlled by different intracellular mechanism peculiarly autophagy [119]. As a matter of fact, conduction of experiments to find the close relation between autophagy and angiogenesis seems to be critical in the context of tissue engineering and regenerative medicine.

Direct effect of autophagy on ECs

Vascular ECs have a fundamental role in preserving normal functions of the cardiovascular organization [120]. Therefore, endothelial dysfunction has been distinguished as a corporate risk factor for almost all kinds of cardiovascular diseases. There is a growing body of literature attempting to understand the effect of autophagy on vascular pathophysiology [121, 122]. It has been well-documented that deficiency of autophagy may be a major mechanism and risk factor that elicits endothelial dysfunction and involved in the regulation of NO bioavailability [123]. In addition to a close relation of NO-autophagy, NO has a critical role in the regulation of mitophagy [124]. Studies demonstrated that autophagy-deficient ECs with blunt NO level promoting ROS and inflammatory cytokine production [125]. Along with the importance of endothelial maturation, endothelial and/or non-endothelial secretome have a pivotal role in the favor of angiogenesis [126]. The paracrine activity of endothelial lineage is mostly dependent on the secretion of factors by releasing exosomes [127]. The induction of autophagy was shown to increase the biogenesis of exosomes carrying endothelial specific factors such as vWF and VEGFR-2 [128, 129].

Emerging evidence also suggests that endothelial autophagy might modulate the uncoupling of eNOS. CAV1/caveolin-1 that is a critical factor of eNOS coupling and NO bioactivity is a key regulator of ECs autophagy [130]. Autophagy flux also embraces angiotensin-II utility required for endothelial function. It is well established that the detrimental effects of angiotensin-II on endothelial dysfunction may be limited by the autophagic system [131]. In patients with diabetes mellitus, one of the risk factors for cardiovascular diseases is vasculitis that occurs through several mechanisms such as hyperglycemia, amplified angiotensin-II production, and an augmented oxidative stress [132, 133]. Therefore, for applying to the clinical approach, it does necessitate establishing elementary in vitro studies for proving a protective effect of autophagy in restraining glucose-caused endothelial damages [133]. Recent investigations have demonstrated that some of the micronutrients with cardiovascular protective potential by enhancing autophagy activity in ECs. For instance, epigallocatechin gallate, resveratrol, and vitamin D were shown to trigger autophagy and diminish palmitic acid-induced gathering of lipid droplets, presumably via an increased lipophagy, lipid catabolism by the autophagosome-lysosome system [134]. Resveratrol, the main cardio-protective component in red wine, attenuates inflammation of EC via the promotion of autophagy [135]. A study showed that curcumin has the potential to induce autophagy and exert cytoprotective effects on EC survival in response to oxidative stress [136]. Also, vitamin D elicits cytoprotective effects in the endothelium by amplifying autophagic flux [137]. These data added a notion that the initiation of autophagy response is a compensatory defensive reaction following the onset of vasculitis.

Autophagy, besides of an indispensable role in the intracellular recycling of proteins and organelles, is also involved in protein secretion in distinct cell types such as beta cells, ECs, mast cells, intestinal paneth cells, and osteoclasts [129, 138141]. Recent evidence suggests that autophagic vacuoles can be directly secreted by ECs under certain conditions such as starvation. Proteomic examination of these autophagic vacuoles revealed that they contain the high levels of vWF [142]. Exocytosis is one of the first lines of defense after vascular injury in ECs. Specific secretory vesicles within the ECs known as Weibel-Palade bodies contain numerous biologically active molecules, notably vWF [143]. It has been well-documented that Weibel-Palade bodies are frequently found near or within autophagosomes and endothelial autophagosomes. Pharmacological inhibitors of autophagy or knockdown of the essential autophagy genes, namely Atg5 or Atg7, inhibit the in vitro secretion of vWF, resulting in prolonged bleeding times. Autophagy, as a consequence, regulates endothelial vWF secretion, and transient pharmacological inhibition of autophagic flux may be a valuable strategy to prevent thrombotic events [129]. Literature point autophagy is insufficient in ECs isolated from individuals with diabetes mellitus. Moreover, Jessica et al. demonstrated that intact autophagy is essential for eNOS signaling in ECs. LA Rocca et al. declared that NO-mediated vasodilation was promoted by the induction of autophagy and highlighted that an impaired autophagy exacerbated endothelial dysfunction in old cells [144].

Under the diabetic condition, an impaired EC function could be reversed by the induction of autophagy [22]. Autophagy improved the angiogenesis potential of human umbilical ECs exposed to high glucose content by induction of tubulogenesis and cell survival activity [145].

Autophagy can be regulated in ECs by compounds circulating in the bloodstream or localized within the sub-endothelial layer of atherosclerotic plaque. In cultured HUVECs, for instance, vitamin D increases the level of factor beclin-1 [137]. Oxidized low-density lipoprotein and AGEs support the formation of autophagosomes [146, 147]. Endostatin, a powerful inhibitor of neovascularization in tumor treatment, initiates autophagic cell death in the human EC line [148]. Interestingly, GRP, an inducer of tubule formation, decreases expression of ATG5, Beclin-1, and LC3 [149]. These findings indicate that autophagy is required for the development of vascular ECs; its appropriate regulation is pivotal during fundamental adaptive responses such as secretion, cell proliferation, and other endothelium functions. Vion et al. previously demonstrated that inefficient autophagy contributed to the development of atherosclerotic plaques in low-shear stress areas, promoting inflammation, apoptosis, and senescent phenotype in ECs [150]. Because of the critical role of endothelial malfunction in the pathogenesis of the vascular-related disease, it would be told that the distractions of autophagy machine in ECs have noteworthy contributions [151].

Based on the critical role of autophagy in the regulation of ECs’ function and angiogenesis, it seems that applying mechanisms which accelerate and/or inhibit autophagy signaling pathway could orient the pro-/anti-angiogenic behavior of endothelial lineage [151]. In recent decades, it was announced that autophagy stimulator/inhibitor could be applied as pharmacologically agents to modulate angiogenesis. Rapamycin, a mTOR inhibitor, shows anti-aging effects in the vascular system and promotes functionality of the endothelial system by increasing the remodeling rate in animal models [152, 153]. The prophylactic autophagy modulation seems to guarantee brain ECs against the apoptosis subjected to ischemic/reperfusion changes [154]. In this regard, some clinical trials were conducted in the manipulation of autophagy effectors to reach beneficial effects during the occurrence of cardiovascular disease. For example, the use of sirolimus was used as autophagy modulators after cardiac allograft transplantation (ClinicalTrials.gov identifier NCT01889992). Outstanding results lead to the prominent importance of autophagic flux for therapeutic approaches. By prescribing a vasodilator agent namely Icariin in ischemic disease, some evidence discovered the simultaneous correlation of endothelial secretion of vWF and induction of autophagy to promote angiogenesis [155]. It seems that the modulation of autophagy must be considered related to stage and intensity of injury. Some documents revealed that the inhibition of autophagy not only increased the angiogenesis rate but also suppressed the pro-angiogenic signaling pathways [156]. Zheng and colleagues reported that activation of Akt/eNOS axis inhibited autophagy and improved angiogenesis and cerebral ischemia-reperfusion injury [156]. A close association exists between autophagy machinery and the inhibition of angiogenesis response in various cells. The autophagic response outcome on tumor progression has been demonstrated in different cancer cell types such as osteosarcoma, glioblastoma, and colorectal cancers [157159]. Wnt/β-Catenin pathway is a key regulator of cell proliferation, differentiation, angiogenesis, and cell death [160] (Fig. 2). However, autophagy induction presents an anti-angiogenic effect via modulation of Wnt/β-catenin signal pathway [161]. Additionally, the application of potent natural autophagy inducer, magnolol (Ery5), disclosed that excessive autophagy has an inhibitory effect on migration and tube formation properties in both human umbilical vein endothelial cells and apoptotic resistant cancer cells while chemical blocking of autophagy by 3-MA or gene silencing of Atg7 and LC3 reversed anti-angiogenic effect of autophagy [162]. VEGFR-2 levels and angiogenesis are reduced following endothelial dysfunction and exposure to AGEs accumulation under diabetic condition (Fig. 2). It was implicated that autophagy plays a key role in VEGFR-2 degradation and impaired angiogenesis [163]. Notably, it was shown that an excessive activity of autophagy is responsible for abrogated angiogenesis potential in MSCs exposed to diabetic serums by P62 overactivity [21]. Rezabakhsh and co-workers examined the pro-/anti-angiogenic potential of diabetic sera on human MSCs. They found that these cells lost endothelial differentiation in in vivo and in vitro conditions [21]. Likewise, the data declared an important correlation between overexpression of autophagic p62 aggregation and angiogenic factors in MSCs subjected to diabetic serums [21]. Peg3 one of the important genes encoding a zinc finger transcription factor contributes to tumor suppression. Upregulation of peg3 increased Beclin-1 protein level and concurrently autophagy induction in ECs which inhibited migratory behavior and in vitro angiogenesis. On the other hand, peg3 stimulates the secretion of thrombospondin-1, as a potent angiogenic factor, and modulates the angiogenesis independent of Beclin-1 transcription [164]. In neuroblastoma with highly florid vascularization, tumor progression and metastasis occurred rapidly with an achieved poor prognosis. Notably, GRP and its receptor GRPR through PI3K-AKT pathway have a pivotal role in cancer-related angiogenesis. By antagonizing GRPR, pro-autophagic proteins are overexpressed and angiogenesis blocked by autophagy-mediated GRP degradation mechanism [165] (Fig. 2). Autophagy is an essential survival pathway by stimulating angiogenesis during the imbalance of oxygen or nutrients supply achieved following anti-angiogenic pharmacotherapy of solid tumors. In this regard, it has been shown that hypoxia-mediated autophagy is considered as a novel mechanism of resistance to anti-angiogenic drugs during the cancer therapy [157]. In fact, angiogenic development of cancer cells under hypoxic condition leads to autophagy induction as a compensatory response via hypoxia-inducible factor-1a/AMPK pathway which increases cancer cell survival rates and drug resistance [159]. Interestingly, chloroquine as a pharmacological autophagy inhibitor could synergize the sunitinib anti-cancer effect by limiting angiogenic capacity probably through upregulation of inducible nitric oxide synthase, increased reactive nitrogen species production, and an increase of anti-oxidant capacity [166]. Moreover, starvation-induced autophagy in cultured BAECs triggered the cell migration and in vitro angiogenesis by activating of VEGF and AKT protein while the use of Atg-5 siRNA reversed the autophagy pro-angiogenic effects on BAECs [167]. It is noteworthy that retinal ECs have a contradictory behavior in comparison with ECs of peripheral vessels. In RF/6A cell line, autophagy as a positive regulator contributed to the hypoxia or high glucose-induced neovascularization under different stress conditions [167, 168] (Fig. 3). It has been found that chemerin, as novel adipose tissue cytokine, also has a stimulatory effect on RF/6A cells angiogenesis by promoting autophagy activity and expression of the autophagy-related proteins LC3 and Beclin-1 increased during chemerin-induced migration and tubular formation [169] (Fig. 3). Endostatin is one of the endogenous angiogenic inhibitors that limited the cell proliferation and migration. Both native and mutant (P125A-endostatin) form of endostatin could activate the autophagy machinery. During primary ECs treatment with P125A-endostatin, the levels of Beclin-1 increased while the apoptotic markers Bcl-2, Bcl-xL, and β-catenin decreased. By enhancing the β-catenin level and Wnt-mediated signaling, endostatin-induced autophagy was inhibited in ECs. Thus, autophagy is a survival response toward the endostatin-mediated apoptotic cell death [170]. Autophagy also was considered a potential angiogenesis-based therapy for cardiovascular diseases. AGGF1 is one of the essential angiogenic factor-induced autophagy through JNK activation and Beclin1-Vps34-Atg14 complex while the AGGF1-mediated migratory behavior, tubular formation, and aortic ring-based angiogenesis required autophagy activity. According to recent findings, AGGF1-based therapy is a candidate for coronary artery disease and myocardial infarction treatment [171] (Fig. 3).
Fig. 2
Fig. 2

Representative image of the anti-angiogenic potential of autophagy. Anti-angiogenic effect autophagy is initiated via the modulation of Wnt/β-catenin axis. The application of autophagy inducer, magnolol (Ery5), has an inhibitory effect on migration and tube formation properties in both human umbilical vein endothelial cells and apoptotic resistant cancer cells while chemical blocking of autophagy by 3-MA or gene silencing of Atg7 and LC3 reversed anti-angiogenic effect of autophagy VEGFR-2 levels and angiogenesis are reduced following endothelial dysfunction and exposure to advanced glycation end products (AGEs) accumulation under diabetic condition. Autophagy plays a key role in VEGFR-2 degradation and impaired angiogenesis. Gastrin-releasing peptide (GRP) and its receptor GRPR through PI3K-AKT pathway have a pivotal role in cancer-related angiogenesis. By antagonizing GRPR, pro-autophagic proteins are overexpressed and angiogenesis blocked by autophagy-mediated GRP degradation mechanism

Fig. 3
Fig. 3

Angiogenic potential of autophagy. Starvation-induced autophagy triggers cell migration and in vitro angiogenesis by activating of VEGF and AKT protein on ECs. AGGF1-induced autophagy is a candidate for coronary artery disease and myocardial infarction treatment. Chemerin, a novel adipose tissue cytokine, also has a stimulatory effect on retinal endothelial cells angiogenesis by promoting autophagy activity and expression of the autophagy-related proteins LC3 and Beclin-1 increased during chemerin-induced migration and tubular formation

Role of autophagy on endothelial differentiation of SCs

To our knowledge, there are a few bodies of experiments targeting the potency of autophagy in controlling of SCs angiogenic orientation toward endothelial phenotype. The simultaneous activation of autophagy effectors and endothelial specific markers such as FLK-1, Tie-2, Cadherin-12, and Cadherin-19 was reported in human bone marrow monocytes after the induction of monocyte chemotactic protein-1. This finding highlights that autophagy actively participates and/or simultaneously is provoked during cell-to-cell trans-differentiation [172]. Li and co-workers showed that the promotion of autophagy via LncRNA WTAPP1 against miRNA 3 and 120 accelerated EPC maturation by modulating Akt/PI3K axis and type 1 metalloproteinase. These data highlight the critical role of autophagy on angiogenesis in either in mature or progenitor cell types [173, 174]. The beneficial effects of autophagy could direct the angiogenic potential of EPCs under diabetic condition by affecting migration and differentiation rate [175177]. These findings propose that inadequate autophagy is a complicity mechanism for endothelial malfunction in diabetes mellitus [22]. Given the importance of endothelial dysfunction in the pathogenesis of atherosclerotic cardiovascular disease, these findings are probably to be clinically correlated [178]. Therefore, pharmacologic interventions directed toward recovering normal autophagic flux may have targeted therapeutic potential in related diseases. In another experiment conducted by Wang and co-workers, they documented that monotropein-inhibited autophagy through AMPK/mTOR signaling in EPCs led to an increased angiogenic differentiation and accelerated wound healing rate [179]. Considering the dual role of autophagy in cytoprotection and cytotoxicity of vascular cells, distinct targeting with careful titration will be required.

Role of autophagy on angiocrine activity of SCs

In addition to trans-differentiation behavior, SC paracrine activity is pivotal in the induction of angiogenesis in the target tissues [180]. MSCs treated with autophagy stimulator such as rapamycin potentially secreted a high level of VEGF via the modulation of ERK phosphorylation and thereby accelerated the regeneration of wound healing. The ablation of autophagy signaling by using si-Beclin-1 blunted pro-angiogenic effects [181]. In a study, preconditioning of rat MSCs with low-energy shock wave therapy promoted the autophagic status with activation of PI3K/AKT/mTOR and NO/cGMP pathways also increased the VEGF factor after transplantation to erectile dysfunction model [119]. The co-culture of periodontal ligament MSCs with ECs exposed to inflammatory condition showed a better angiogenic behavior. High levels of MSC-derived bFGF and angiogenin factors were detected [182]. In line with these reports, autophagy accelerates angiogenesis-promoting capacity of SCs even in the inflammatory environment. It should be noted that autophagy activation not only promotes the angiocrine capacity of SCs but also activated abnormal conditions. For example, it was shown that EPCs autophagy response is activated after being treated with high glucose content (30 mM) or hypoxic condition [183, 184]. The activation of autophagy decreases the number of apoptotic cells and forces cells to tolerate insulting conditions. Commensurate with these comments, autophagy is able to increase the paracrine activity of SCs in response to various conditions.

Conclusion

In conclusion, findings strongly clarify that autophagy dual effect on angiogenic behavior is entirely dependent on cell type, cellular demands, and other conditions which need to be evaluated by further clinical trials and more comprehensive tests.

Notes

Abbreviations

3-MA: 

3-Methyladenine

AGEs: 

Advanced glycation end products

AMPK: 

Adenosine monophosphate kinase

ASCs: 

Adult stem cells

ATG: 

Autophagy-related genes

BAECs: 

Bovine aortic endothelial cells

CMA: 

Chaperone-mediated autophagy

CPCs: 

Cardiac stem cells

CSCs: 

Cancer stem cells

ECs: 

Endothelial cells

EPCs: 

Endothelial progenitor cells

ESCs: 

Embryonic stem cells

FGF: 

Fibroblast growth factor

GRP: 

Gastrin-releasing peptide

HMBOX1: 

Homeobox-containing 1

HSCs: 

Hematopoietic stem cells

LAMP2A: 

Lysosomal-associated membrane protein type 2A

LIF: 

Leukemia inhibitory factor

MPCs: 

Muscle progenitor cells

MSCs: 

Mesenchymal stem cells

mTOR: 

Mammalian Target of Rapamycin

NO: 

Nitric oxide

NSCs: 

Neuronal stem cells

PI3K: 

Phosphatidylinositol 3-kinase

PTEN: 

Phosphatase and tensin homolog

RF/6A: 

Rhesus macaque choroid-retinal endothelial

ROS: 

Reactive oxygen species

SCs: 

Stem cells

SIRT-1: 

Sirt1

SNARE: 

Soluble N-ethylmaleimide-sensitive factor attachment protein receptor

ULK1: 

Ubiquitin-like kinase 1

VEGFR-2: 

Vascular endothelial growth factor receptor 2

Vps: 

Vesicle-mediated vacuolar protein sorting

vWF: 

Von Willebrand factor

Declarations

Acknowledgements

This study is originated from a Ph.D. thesis and supported by a grant from Tabriz University of Medical Sciences. The authors wish to thank the personnel of the Stem Cell Research Center for kindest guidance and help.

Funding

This study is originated from a Ph.D. and supported by a grant from Tabriz University of Medical Sciences.

Availability of data and materials

None applicable.

Authors’ contributions

MH and AR collected the data and prepared the initial draft of the manuscript preparation; MP monitored the corrected collected data. RR designed the study and performed the final conceptualization and revised the manuscript, and MN participated in the final conceptualization. All authors read the manuscript and approved the final manuscript.

Ethics approval and consent to participate

None applicable.

Consent for publication

All authors agreed to publish this manuscript.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Clinical Biochemistry and Laboratory Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
(2)
Stem Cell Research Center, Tabriz University of Medical Sciences, Imam Reza St., Golgasht St., Tabriz, 5166614756, Iran
(3)
Stem Cell And Regenerative Medicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran
(4)
Emergency Medicine Research Team, Tabriz University of Medical Sciences, Tabriz, Iran
(5)
Department of Applied Drug Research, Tabriz University of Medical Sciences, Tabriz, Iran
(6)
Department of Applied Cell Sciences, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran

References

  1. Zhao J, Zhai B, Gygi SP, Goldberg AL. mTOR inhibition activates overall protein degradation by the ubiquitin proteasome system as well as by autophagy. Proc Natl Acad Sci. 2015;112(52):15790–7.PubMedView ArticlePubMed CentralGoogle Scholar
  2. Galluzzi L, Baehrecke EH, Ballabio A, Boya P, Bravo-San Pedro JM, Cecconi F, Choi AM, Chu CT, Codogno P, Colombo MI. Molecular definitions of autophagy and related processes. EMBO J. 2017;36(13):1811–36.PubMedPubMed CentralView ArticleGoogle Scholar
  3. Stolz A, Ernst A, Dikic I. Cargo recognition and trafficking in selective autophagy. Nat Cell Biol. 2014;16(6):495.PubMedView ArticlePubMed CentralGoogle Scholar
  4. Sotthibundhu A, Promjuntuek W, Liu M, Shen S, Noisa P. Roles of autophagy in controlling stem cell identity: a perspective of self-renewal and differentiation. Cell Tissue Res. 2018;374(2):205-16.PubMedView ArticlePubMed CentralGoogle Scholar
  5. Hardie DG. AMPK and autophagy get connected. EMBO J. 2011;30(4):634–5. https://doi.org/10.1038/emboj.2011.12.View ArticlePubMedPubMed CentralGoogle Scholar
  6. Mizushima N. The role of the Atg1/ULK1 complex in autophagy regulation. Curr Opin Cell Biol. 2010;22(2):132–9.PubMedView ArticlePubMed CentralGoogle Scholar
  7. Ghavami S, Shojaei S, Yeganeh B, Ande SR, Jangamreddy JR, Mehrpour M, Christoffersson J, Chaabane W, Moghadam AR, Kashani HH. Autophagy and apoptosis dysfunction in neurodegenerative disorders. Prog Neurobiol. 2014;112:24–49.View ArticleGoogle Scholar
  8. Orsi A, Razi M, Dooley H, Robinson D, Weston A, Collinson L, Tooze S. Dynamic and transient interactions of Atg9 with autophagosomes, but not membrane integration, are required for autophagy. Mol Biol Cell. 2012;23(10):1860–73.PubMedPubMed CentralView ArticleGoogle Scholar
  9. Zhong Y, Wang QJ, Li X, Yan Y, Backer JM, Chait BT, Heintz N, Yue Z. Distinct regulation of autophagic activity by Atg14L and Rubicon associated with Beclin 1–phosphatidylinositol-3-kinase complex. Nat Cell Biol. 2009;11(4):468.PubMedPubMed CentralView ArticleGoogle Scholar
  10. Hamasaki M, Furuta N, Matsuda A, Nezu A, Yamamoto A, Fujita N, Oomori H, Noda T, Haraguchi T, Hiraoka Y. Autophagosomes form at ER–mitochondria contact sites. Nature. 2013;495(7441):389.PubMedView ArticlePubMed CentralGoogle Scholar
  11. Kawamata T, Kamada Y, Kabeya Y, Sekito T, Ohsumi Y. Organization of the pre-autophagosomal structure responsible for autophagosome formation. Mol Biol Cell. 2008;19(5):2039–50. https://doi.org/10.1091/mbc.E07-10-1048.View ArticlePubMedPubMed CentralGoogle Scholar
  12. Marquez RT, Xu L. Bcl-2:Beclin 1 complex: multiple, mechanisms regulating autophagy/apoptosis toggle switch. Am J Cancer Res. 2012;2(2):214–21.PubMedPubMed CentralGoogle Scholar
  13. Glick D, Barth S, Macleod KF. Autophagy: cellular and molecular mechanisms. J Pathol. 2010;221(1):3–12.PubMedPubMed CentralView ArticleGoogle Scholar
  14. Weidberg H, Shvets E, Elazar Z. Biogenesis and cargo selectivity of autophagosomes. Annu Rev Biochem. 2011;80:125–56.PubMedView ArticlePubMed CentralGoogle Scholar
  15. Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, Agholme L, Agnello M, Agostinis P, Aguirre-Ghiso JA. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 2012;8(4):445–544.PubMedPubMed CentralView ArticleGoogle Scholar
  16. Atlashkin V, Kreykenbohm V, Eskelinen E-L, Wenzel D, Fayyazi A, von Mollard GF. Deletion of the SNARE vti1b in mice results in the loss of a single SNARE partner, syntaxin 8. Mol Cell Biol. 2003;23(15):5198–207.PubMedPubMed CentralView ArticleGoogle Scholar
  17. Lee J-A, Beigneux A, Ahmad ST, Young SG, Gao F-B. ESCRT-III dysfunction causes autophagosome accumulation and neurodegeneration. Curr Biol. 2007;17(18):1561–7.View ArticleGoogle Scholar
  18. Mauvezin C, Nagy P, Juhász G, Neufeld TP. Autophagosome–lysosome fusion is independent of V-ATPase-mediated acidification. Nat Commun. 2015;6:7007. https://doi.org/10.1038/ncomms8007.View ArticlePubMedPubMed CentralGoogle Scholar
  19. Seibenhener ML, Du Y, Diaz-Meco M-T, Moscat J, Wooten MC, Wooten MW. A role for sequestosome 1/p62 in mitochondrial dynamics, import and genome integrity. Biochim Biophys Acta. 2013;1833(3):452–9. https://doi.org/10.1016/j.bbamcr.2012.11.004.PubMedView ArticlePubMed CentralGoogle Scholar
  20. Mizushima N, Yoshimori T. How to interpret LC3 immunoblotting. Autophagy. 2007;3(6):542–5.PubMedView ArticlePubMed CentralGoogle Scholar
  21. Rezabakhsh A, Cheraghi O, Nourazarian A, Hassanpour M, Kazemi M, Ghaderi S, Faraji E, Rahbarghazi R, Avci ÇB, Bagca BG. Type 2 diabetes inhibited human mesenchymal stem cells angiogenic response by over-activity of the autophagic pathway. J Cell Biochem. 2017;118(6):1518–30.PubMedView ArticlePubMed CentralGoogle Scholar
  22. Fetterman JL, Holbrook M, Flint N, Feng B, Bretόn-Romero R, Linder EA, Berk BD, Duess M-A, Farb MG, Gokce N. Restoration of autophagy in endothelial cells from patients with diabetes mellitus improves nitric oxide signaling. Atherosclerosis. 2016;247:207–17.PubMedPubMed CentralView ArticleGoogle Scholar
  23. Rezabakhsh A, Fathi F, Saghaei HB, Malekinejad H, Montaseri A, Rahbarghazi R, Garjani A. Silibinin protects human endothelial cells from high glucose-induced injury by enhancing autophagic response. J Cell Biochem. 2018.Google Scholar
  24. Nikravesh MR, Jalali M, Ghafaripoor HA, Sanchooli J, Hamidi D. Therapeutic potential of umbilical cord blood stem cells on brain damage of a model of stroke. J Cardiovasc Thoracic Res. 2011;3(4):117.Google Scholar
  25. Rumman M, Dhawan J, Kassem M. Concise review: quiescence in adult stem cells: biological significance and relevance to tissue regeneration. Stem Cells. 2015;33(10):2903–12.PubMedView ArticlePubMed CentralGoogle Scholar
  26. Grompe M. Adult versus embryonic stem cells: it’s still a tie. Mol Ther. 2002;6(3):303–5.PubMedView ArticlePubMed CentralGoogle Scholar
  27. Hong SN, Dunn JC, Stelzner M, Martín MG. Concise review: the potential use of intestinal stem cells to treat patients with intestinal failure. Stem Cells Transl Med. 2017;6(2):666–76.PubMedView ArticlePubMed CentralGoogle Scholar
  28. Loza-Coll MA, Jones DL. Simultaneous control of stemness and differentiation by the transcription factor Escargot in adult stem cells: how can we tease them apart? Fly. 2016;10(2):53–9.PubMedPubMed CentralView ArticleGoogle Scholar
  29. Lu C-C, Chu P-Y, Hsia S-M, Wu C-H, Tung Y-T, Yen G-C. Insulin induction instigates cell proliferation and metastasis in human colorectal cancer cells. Int J Oncol. 2017;50(2):736–44.PubMedView ArticlePubMed CentralGoogle Scholar
  30. Phadwal K, Watson AS, Simon AK. Tightrope act: autophagy in stem cell renewal, differentiation, proliferation, and aging. Cell Mol Life Sci. 2013;70(1):89–103. https://doi.org/10.1007/s00018-012-1032-3.View ArticlePubMedPubMed CentralGoogle Scholar
  31. Boya P, Codogno P, Rodriguez-Muela N. Autophagy in stem cells: repair, remodelling and metabolic reprogramming. Development. 2018;145(4):dev146506.PubMedView ArticlePubMed CentralGoogle Scholar
  32. Salemi S, Yousefi S, Constantinescu MA, Fey MF, Simon H-U. Autophagy is required for self-renewal and differentiation of adult human stem cells. Cell Res. 2012;22(2):432.PubMedView ArticlePubMed CentralGoogle Scholar
  33. Hanna JH, Saha K, Jaenisch R. Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. Cell. 2010;143(4):508–25.PubMedPubMed CentralView ArticleGoogle Scholar
  34. Jopling C, Boue S, Belmonte JCI. Dedifferentiation, transdifferentiation and reprogramming: three routes to regeneration. Nat Rev Mol Cell Biol. 2011;12(2):79.PubMedView ArticlePubMed CentralGoogle Scholar
  35. Ma H, Su L, Yue H, Yin X, Zhao J, Zhang S, Kung H, Xu Z, Miao J. HMBOX1 interacts with MT2A to regulate autophagy and apoptosis in vascular endothelial cells. Sci Rep. 2015;5:15121.PubMedPubMed CentralView ArticleGoogle Scholar
  36. Lee K-W, Yook J-Y, Son M-Y, Kim M-J, Koo D-B, Han Y-M, Cho YS. Rapamycin promotes the osteoblastic differentiation of human embryonic stem cells by blocking the mTOR pathway and stimulating the BMP/Smad pathway. Stem Cells Dev. 2010;19(4):557–68.PubMedView ArticlePubMed CentralGoogle Scholar
  37. Ou X, Lee MR, Huang X, Messina-Graham S, Broxmeyer HE. SIRT1 positively regulates autophagy and mitochondria function in embryonic stem cells under oxidative stress. Stem cells (Dayton, Ohio). 2014;32(5):1183–94. https://doi.org/10.1002/stem.1641.View ArticleGoogle Scholar
  38. Xing J, Liu H, Yang H, Chen R, Chen Y, Xu J. Upregulation of Unc-51-like kinase 1 by nitric oxide stabilizes SIRT1, independent of autophagy. PLoS One. 2014;9(12):e116165. PubMedPubMed CentralView ArticleGoogle Scholar
  39. Cherepkova MY, Sineva GS, Pospelov VA. Leukemia inhibitory factor (LIF) withdrawal activates mTOR signaling pathway in mouse embryonic stem cells through the MEK/ERK/TSC2 pathway. Cell Death Dis. 2017;7(1):e2050.View ArticleGoogle Scholar
  40. Onishi K, Zandstra PW. LIF signaling in stem cells and development. Dev. 2015;142(13):2230-6.PubMedView ArticlePubMed CentralGoogle Scholar
  41. Liu P, Liu K, Gu H, Wang W, Gong J, Zhu Y, Zhao Q, Cao J, Han C, Gao F. High autophagic flux guards ESC identity through coordinating autophagy machinery gene program by FOXO1. Cell Death Differ. 2017;24(10):1672.PubMedPubMed CentralView ArticleGoogle Scholar
  42. Zhang X, Yalcin S, Lee D-F, Yeh T-YJ, Lee S-M, Su J, Mungamuri SK, Rimmelé P, Kennedy M, Sellers R. FOXO1 is an essential regulator of pluripotency in human embryonic stem cells. Nat Cell Biol. 2011;13(9):1092.PubMedPubMed CentralView ArticleGoogle Scholar
  43. Qu X, Zou Z, Sun Q, Luby-Phelps K, Cheng P, Hogan RN, Gilpin C, Levine B. Autophagy gene-dependent clearance of apoptotic cells during embryonic development. Cell. 2007;128(5):931–46.View ArticleGoogle Scholar
  44. Kuo T-C, Chen C-T, Baron D, Onder TT, Loewer S, Almeida S, Weismann CM, Xu P, Houghton J-M, Gao F-B. Midbody accumulation through evasion of autophagy contributes to cellular reprogramming and tumorigenicity. Nat Cell Biol. 2011;13(10):1214.PubMedPubMed CentralView ArticleGoogle Scholar
  45. Tsukamoto S, Kuma A, Murakami M, Kishi C, Yamamoto A, Mizushima N. Autophagy is essential for preimplantation development of mouse embryos. Science. 2008;321(5885):117–20.PubMedPubMed CentralView ArticleGoogle Scholar
  46. Arsov I, Adebayo A, Kucerova-Levisohn M, Haye J, MacNeil M, Papavasiliou FN, Yue Z, Ortiz BD. A role for autophagic protein beclin 1 early in lymphocyte development. J Immunol. 2011:1002223.Google Scholar
  47. Lee HJ, Gutierrez-Garcia R, Vilchez D. Embryonic stem cells: a novel paradigm to study proteostasis? FEBS J. 2017;284(3):391–8.PubMedView ArticlePubMed CentralGoogle Scholar
  48. Mortensen M, Soilleux EJ, Djordjevic G, Tripp R, Lutteropp M, Sadighi-Akha E, Stranks AJ, Glanville J, Knight S, Jacobsen S-EW. The autophagy protein Atg7 is essential for hematopoietic stem cell maintenance. J Exp Med. 2011;208(3):455–67.PubMedPubMed CentralView ArticleGoogle Scholar
  49. Fimia GM, Stoykova A, Romagnoli A, Giunta L, Di Bartolomeo S, Nardacci R, Corazzari M, Fuoco C, Ucar A, Schwartz P (2007) Ambra1 regulates autophagy and development of the nervous system. Nature 447 (7148):1121.Google Scholar
  50. Mortensen M, Watson AS, Simon AK. Lack of autophagy in the hematopoietic system leads to loss of hematopoietic stem cell function and dysregulated myeloid proliferation. Autophagy. 2011;7(9):1069–70.PubMedPubMed CentralView ArticleGoogle Scholar
  51. Pua HH, Dzhagalov I, Chuck M, Mizushima N, He Y-W. A critical role for the autophagy gene Atg5 in T cell survival and proliferation. J Exp Med. 2007;204(1):25–31.PubMedPubMed CentralView ArticleGoogle Scholar
  52. Shaw RJ, Kosmatka M, Bardeesy N, Hurley RL, Witters LA, DePinho RA, Cantley LC. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc Natl Acad Sci. 2004;101(10):3329–35.PubMedView ArticlePubMed CentralGoogle Scholar
  53. Gurumurthy S, Xie SZ, Alagesan B, Kim J, Yusuf RZ, Saez B, Tzatsos A, Ozsolak F, Milos P, Ferrari F. The Lkb1 metabolic sensor maintains haematopoietic stem cell survival. Nature. 2010;468(7324):659.PubMedPubMed CentralView ArticleGoogle Scholar
  54. Meenhuis A, van Veelen PA, de Looper H, van Boxtel N, van den Berge IJ, Sun SM, Taskesen E, Stern P, de Ru AH, van Adrichem AJ. MiR-17/20/93/106 promote hematopoietic cell expansion by targeting sequestosome 1-regulated pathways in mice. Blood:blood-2011-2002. 2011. https://doi.org/10.1182/blood-2011-02-336487.PubMedPubMed CentralView ArticleGoogle Scholar
  55. Cohen-Kaplan V, Livneh I, Avni N, Fabre B, Ziv T, Kwon YT, Ciechanover A. p62-and ubiquitin-dependent stress-induced autophagy of the mammalian 26S proteasome. Proc Natl Acad Sci. 2016;113(47):E7490–9.PubMedView ArticlePubMed CentralGoogle Scholar
  56. Kang Y-A, Sanalkumar R, O'geen H, Linnemann AK, Chang C-J, Bouhassira EE, Farnham PJ, Keles S, Bresnick EH. Autophagy driven by a master regulator of hematopoiesis. Mol Cell Biol. 2012;32(1):226-39.PubMedView ArticlePubMed CentralGoogle Scholar
  57. Hu Y, Huang Y, Yi Y, Wang H, Liu B, Yu J, Wang D. Single-cell RNA sequencing highlights transcription activity of autophagy-related genes during hematopoietic stem cell formation in mouse embryos. Autophagy. 2017;13(4):770–1.PubMedPubMed CentralView ArticleGoogle Scholar
  58. Ito K, Turcotte R, Cui J, Zimmerman SE, Pinho S, Mizoguchi T, Arai F, Runnels JM, Alt C, Teruya-Feldstein J. Self-renewal of a purified Tie2+ hematopoietic stem cell population relies on mitochondrial clearance. Science. 2016;354(6316):1156–60.PubMedPubMed CentralView ArticleGoogle Scholar
  59. Ho TT, Warr MR, Adelman ER, Lansinger OM, Flach J, Verovskaya EV, Figueroa ME, Passegué E. Autophagy maintains the metabolism and function of young and old stem cells. Nature. 2017;543(7644):205.PubMedPubMed CentralView ArticleGoogle Scholar
  60. Matsui K, Ezoe S, Oritani K, Shibata M, Tokunaga M, Fujita N, Tanimura A, Sudo T, Tanaka H, McBurney MW. NAD-dependent histone deacetylase, SIRT1, plays essential roles in the maintenance of hematopoietic stem cells. Biochem Biophys Res Commun. 2012;418(4):811–7.PubMedView ArticlePubMed CentralGoogle Scholar
  61. Rimmelé P, Bigarella CL, Liang R, Izac B, Dieguez-Gonzalez R, Barbet G, Donovan M, Brugnara C, Blander JM, Sinclair DA. Aging-like phenotype and defective lineage specification in SIRT1-deleted hematopoietic stem and progenitor cells. Stem Cell Rep. 2014;3(1):44–59.View ArticleGoogle Scholar
  62. Warr MR, Binnewies M, Flach J, Reynaud D, Garg T, Malhotra R, Debnath J, Passegué E. FOXO3A directs a protective autophagy program in haematopoietic stem cells. Nature. 2013;494(7437):323.PubMedPubMed CentralView ArticleGoogle Scholar
  63. Mathew R, Kongara S, Beaudoin B, Karp CM, Bray K, Degenhardt K, Chen G, Jin S, White E. Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev. 2007;21(11):1367–81.PubMedPubMed CentralView ArticleGoogle Scholar
  64. Vessoni AT, Filippi-Chiela EC, Menck CF, Lenz G. Autophagy and genomic integrity. Cell Death Differ. 2013;20(11):1444–54. https://doi.org/10.1038/cdd.2013.103.View ArticlePubMedPubMed CentralGoogle Scholar
  65. Zeng M, Zhou J-N. Roles of autophagy and mTOR signaling in neuronal differentiation of mouse neuroblastoma cells. Cell Signal. 2008;20(4):659–65.PubMedView ArticlePubMed CentralGoogle Scholar
  66. Paik J-h, Ding Z, Narurkar R, Ramkissoon S, Muller F, Kamoun WS, Chae S-S, Zheng H, Ying H, Mahoney J. FoxOs cooperatively regulate diverse pathways governing neural stem cell homeostasis. Cell Stem Cell. 2009;5(5):540–53.PubMedPubMed CentralView ArticleGoogle Scholar
  67. Morgado AL, Xavier JM, Dionísio PA, Ribeiro MF, Dias RB, Sebastião AM, Solá S, Rodrigues CM. MicroRNA-34a modulates neural stem cell differentiation by regulating expression of synaptic and autophagic proteins. Mol Neurobiol. 2015;51(3):1168–83.PubMedView ArticlePubMed CentralGoogle Scholar
  68. Wang C, Chen S, Yeo S, Karsli-Uzunbas G, White E, Mizushima N, Virgin HW, Guan J-L. Elevated p62/SQSTM1 determines the fate of autophagy-deficient neural stem cells by increasing superoxide. J Cell Biol. 2016;212(5):545–60.PubMedPubMed CentralView ArticleGoogle Scholar
  69. Wang C, Yeo S, Haas MA, Guan J-L. Autophagy gene FIP200 in neural progenitors non–cell autonomously controls differentiation by regulating microglia. J Cell Biol. 2017;216(8):2581–96.PubMedPubMed CentralView ArticleGoogle Scholar
  70. Zhang Y, Wang J, Chen G, Fan D, Deng M. Inhibition of Sirt1 promotes neural progenitors toward motoneuron differentiation from human embryonic stem cells. Biochem Biophys Res Commun. 2011;404(2):610–4.PubMedView ArticlePubMed CentralGoogle Scholar
  71. Aranha MM, Santos DM, Solá S, Steer CJ, Rodrigues CM. miR-34a regulates mouse neural stem cell differentiation. PLoS One. 2011;6(8):e21396.PubMedPubMed CentralView ArticleGoogle Scholar
  72. Vázquez P, Arroba AI, Cecconi F, de la Rosa EJ, Boya P, De Pablo F. Atg5 and Ambra1 differentially modulate neurogenesis in neural stem cells. Autophagy. 2012;8(2):187–99.PubMedView ArticlePubMed CentralGoogle Scholar
  73. Lv X, Jiang H, Li B, Liang Q, Wang S, Zhao Q, Jiao J. The crucial role of Atg5 in cortical neurogenesis during early brain development. Sci Rep. 2014;4:6010.PubMedPubMed CentralView ArticleGoogle Scholar
  74. Pivtoraiko VN, Stone SL, Roth KA, Shacka JJ. Oxidative stress and autophagy in the regulation of lysosome-dependent neuron death. Antioxid Redox Signal. 2009;11(3):481–96.PubMedPubMed CentralView ArticleGoogle Scholar
  75. Walls KC, Ghosh AP, Franklin AV, Klocke BJ, Ballestas M, Shacka JJ, Zhang J, Roth KA. Lysosome dysfunction triggers Atg7-dependent neural apoptosis. J Biol Chem. 2010;285(14):10497–507.PubMedPubMed CentralView ArticleGoogle Scholar
  76. Ito K, Hirao A, Arai F, Matsuoka S, Takubo K, Hamaguchi I, Nomiyama K, Hosokawa K, Sakurada K, Nakagata N. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature. 2004;431(7011):997.PubMedView ArticlePubMed CentralGoogle Scholar
  77. Ito K, Hirao A, Arai F, Takubo K, Matsuoka S, Miyamoto K, Ohmura M, Naka K, Hosokawa K, Ikeda Y. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat Med. 2006;12(4):446.PubMedView ArticlePubMed CentralGoogle Scholar
  78. Liang Q, Luo Z, Zeng J, Chen W, Foo S-S, Lee S-A, Ge J, Wang S, Goldman SA, Zlokovic BV. Zika virus NS4A and NS4B proteins deregulate Akt-mTOR signaling in human fetal neural stem cells to inhibit neurogenesis and induce autophagy. Cell Stem Cell. 2016;19(5):663–71.PubMedPubMed CentralView ArticleGoogle Scholar
  79. Hong CJ, Park H, Yu S-W. Autophagy for the quality control of adult hippocampal neural stem cells. Brain Res. 2016;1649:166–72.PubMedView ArticlePubMed CentralGoogle Scholar
  80. Chung KM, Jeong E-J, Park H, An H-K, Yu S-W. Mediation of autophagic cell death by type 3 ryanodine receptor (RyR3) in adult hippocampal neural stem cells. Front Cell Neurosci. 2016;10:116.PubMedPubMed CentralGoogle Scholar
  81. Sordella R, Jiang W, Chen G-C, Curto M, Settleman J. Modulation of Rho GTPase signaling regulates a switch between adipogenesis and myogenesis. Cell. 2003;113(2):147–58.PubMedView ArticlePubMed CentralGoogle Scholar
  82. Eom YW, Oh J-E, Lee JI, Baik SK, Rhee K-J, Shin HC, Kim YM, Ahn CM, Kong JH, Kim HS. The role of growth factors in maintenance of stemness in bone marrow-derived mesenchymal stem cells. Biochem Biophys Res Commun. 2014;445(1):16–22.PubMedView ArticlePubMed CentralGoogle Scholar
  83. Yeo SK, Wen J, Chen S, Guan J-L. Autophagy differentially regulates distinct breast cancer stem-like cells in murine models via EGFR/Stat3 and Tgfß/Smad signaling. Cancer Res:Canres. 2016;2946(2015).Google Scholar
  84. Bohensky J, Shapiro IM, Leshinsky S, Terkhorn SP, Adams CS, Srinivas V. HIF-1 regulation of chondrocyte apoptosis: induction of the autophagic pathway. Autophagy. 2007;3(3):207–14.PubMedView ArticlePubMed CentralGoogle Scholar
  85. Caramés B, Taniguchi N, Otsuki S, Blanco FJ, Lotz M. Autophagy is a protective mechanism in normal cartilage and its aging-related loss is linked with cell death and osteoarthritis. Arthritis Rheum. 2010;62(3):791–801. https://doi.org/10.1002/art.27305.View ArticlePubMedPubMed CentralGoogle Scholar
  86. Liu F, Fang F, Yuan H, Yang D, Chen Y, Williams L, Goldstein SA, Krebsbach PH, Guan JL. Suppression of autophagy by FIP200 deletion leads to osteopenia in mice through the inhibition of osteoblast terminal differentiation. J Bone Miner Res. 2013;28(11):2414–30.PubMedPubMed CentralView ArticleGoogle Scholar
  87. Pantovic A, Krstic A, Janjetovic K, Kocic J, Harhaji-Trajkovic L, Bugarski D, Trajkovic V. Coordinated time-dependent modulation of AMPK/Akt/mTOR signaling and autophagy controls osteogenic differentiation of human mesenchymal stem cells. Bone. 2013;52(1):524–31.PubMedView ArticlePubMed CentralGoogle Scholar
  88. Zhang Q, Yang Y-J, Wang H, Dong Q-T, Wang T-J, Qian H-Y, Xu H. Autophagy activation: a novel mechanism of atorvastatin to protect mesenchymal stem cells from hypoxia and serum deprivation via AMP-activated protein kinase/mammalian target of rapamycin pathway. Stem Cells Dev. 2012;21(8):1321–32.PubMedPubMed CentralView ArticleGoogle Scholar
  89. Sanchez CG, Penfornis P, Oskowitz AZ, Boonjindasup AG, Cai DZ, Dhule SS, Rowan BG, Kelekar A, Krause DS, Pochampally RR. Activation of autophagy in mesenchymal stem cells provides tumor stromal support. Carcinogenesis. 2011;32(7):964–72.PubMedPubMed CentralView ArticleGoogle Scholar
  90. Amiri F, Molaei S, Bahadori M, Nasiri F, Deyhim MR, Jalili MA, Nourani MR, Roudkenar MH. Autophagy-modulated human bone marrow-derived mesenchymal stem cells accelerate liver restoration in mouse models of acute liver failure. Iran Biomed J. 2016;20(3):135.PubMedPubMed CentralGoogle Scholar
  91. Shin JY, Park HJ, Kim HN, Oh SH, Bae J-S, Ha H-J, Lee PH. Mesenchymal stem cells enhance autophagy and increase β-amyloid clearance in Alzheimer disease models. Autophagy. 2014;10(1):32–44.PubMedPubMed CentralView ArticleGoogle Scholar
  92. Zhang S, Cai G, Fu B, Feng Z, Ding R, Bai X, Liu W, Zhuo L, Sun L, Liu F. SIRT1 is required for the effects of rapamycin on high glucose-inducing mesangial cells senescence. Mech Ageing Dev. 2012;133(6):387–400.PubMedView ArticlePubMed CentralGoogle Scholar
  93. Liu X, Chen H, Zhu W, Chen H, Hu X, Jiang Z, Xu Y, Zhou Y, Wang K, Wang L. Transplantation of SIRT1-engineered aged mesenchymal stem cells improves cardiac function in a rat myocardial infarction model. J Heart Lung Transplant. 2014;33(10):1083–92.PubMedView ArticlePubMed CentralGoogle Scholar
  94. Wang YX, Rudnicki MA. Satellite cells, the engines of muscle repair. Nat Rev Mol Cell Biol. 2012;13(2):127.View ArticleGoogle Scholar
  95. García-Prat L, Martínez-Vicente M, Perdiguero E, Ortet L, Rodríguez-Ubreva J, Rebollo E, Ruiz-Bonilla V, Gutarra S, Ballestar E, Serrano AL. Autophagy maintains stemness by preventing senescence. Nature. 2016;529(7584):37.PubMedView ArticlePubMed CentralGoogle Scholar
  96. García-Prat L, Muñoz-Cánoves P, Martinez-Vicente M. Dysfunctional autophagy is a driver of muscle stem cell functional decline with aging. Autophagy. 2016;12(3):612–3.PubMedPubMed CentralView ArticleGoogle Scholar
  97. Eisenberg T, Abdellatif M, Schroeder S, Primessnig U, Stekovic S, Pendl T, Harger A, Schipke J, Zimmermann A, Schmidt A. Cardioprotection and lifespan extension by the natural polyamine spermidine. Nat Med. 2016;22(12):1428.PubMedPubMed CentralView ArticleGoogle Scholar
  98. Solanas G, Peixoto FO, Perdiguero E, Jardí M, Ruiz-Bonilla V, Datta D, Symeonidi A, Castellanos A, Welz P-S, Caballero JM. Aged stem cells reprogram their daily rhythmic functions to adapt to stress. Cell. 2017;170(4):678–692. e620.PubMedView ArticlePubMed CentralGoogle Scholar
  99. Tang AH, Rando TA. Induction of autophagy supports the bioenergetic demands of quiescent muscle stem cell activation. EMBO J. 2014;33(23):2782–97.PubMedPubMed CentralView ArticleGoogle Scholar
  100. Zhang J, Liu J, Huang Y, Chang JY, Liu L, McKeehan WL, Martin JF, Wang F. FRS2α-mediated FGF signals suppress premature differentiation of cardiac stem cells through regulating autophagy ActivityNovelty and significance. Circ Res. 2012;110(4):e29–39.PubMedView ArticlePubMed CentralGoogle Scholar
  101. Prathipati P, Nandi SS, Mishra PK. Stem cell-derived exosomes, autophagy, extracellular matrix turnover, and miRNAs in cardiac regeneration during stem cell therapy. Stem Cell Rev Rep. 2017;13(1):79–91.View ArticleGoogle Scholar
  102. Ojha R, Bhattacharyya S, Singh SK. Autophagy in cancer stem cells: a potential link between chemoresistance, recurrence, and metastasis. BioRes Open Access. 2015;4(1):97–108.PubMedPubMed CentralView ArticleGoogle Scholar
  103. Auberger P, Puissant A. Autophagy, a key mechanism of oncogenesis and resistance in leukemia. Blood:blood-2016-2007. 2016. https://doi.org/10.1182/blood-2016-07-692707.PubMedView ArticlePubMed CentralGoogle Scholar
  104. Beck B, Blanpain C. Unravelling cancer stem cell potential. Nat Rev Cancer. 2013;13(10):727.PubMedPubMed CentralView ArticleGoogle Scholar
  105. Pattabiraman DR, Weinberg RA. Tackling the cancer stem cells—what challenges do they pose? Nat Rev Drug Discov. 2014;13(7):497.PubMedPubMed CentralView ArticleGoogle Scholar
  106. Galluzzi L, Pietrocola F, Bravo-San Pedro JM, Amaravadi RK, Baehrecke EH, Cecconi F, Codogno P, Debnath J, Gewirtz DA, Karantza V. Autophagy in malignant transformation and cancer progression. EMBO J. 2015;34(7):856–80.PubMedPubMed CentralView ArticleGoogle Scholar
  107. Pascual G, Avgustinova A, Mejetta S, Martín M, Castellanos A, Attolini CS-O, Berenguer A, Prats N, Toll A, Hueto JA. Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature. 2017;541(7635):41.PubMedView ArticlePubMed CentralGoogle Scholar
  108. Yilmaz ÖH, Valdez R, Theisen BK, Guo W, Ferguson DO, Wu H, Morrison SJ. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature. 2006;441(7092):475.PubMedView ArticlePubMed CentralGoogle Scholar
  109. Wang S, Garcia AJ, Wu M, Lawson DA, Witte ON, Wu H. Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation. Proc Natl Acad Sci. 2006;103(5):1480–5.PubMedView ArticlePubMed CentralGoogle Scholar
  110. Gong C, Bauvy C, Tonelli G, Yue W, Delomenie C, Nicolas V, Zhu Y, Domergue V, Marin-Esteban V, Tharinger H. Beclin 1 and autophagy are required for the tumorigenicity of breast cancer stem-like/progenitor cells. Oncogene. 2013;32(18):2261.PubMedView ArticlePubMed CentralGoogle Scholar
  111. Yue W, Hamaï A, Tonelli G, Bauvy C, Nicolas V, Tharinger H, Codogno P, Mehrpour M. Inhibition of the autophagic flux by salinomycin in breast cancer stem-like/progenitor cells interferes with their maintenance. Autophagy. 2013;9(5):714–29.PubMedPubMed CentralView ArticleGoogle Scholar
  112. Yang H-Z, Ma Y, Zhou Y, Xu L-M, Chen X-J, Ding W-B, Zou H-B. Autophagy contributes to the enrichment and survival of colorectal cancer stem cells under oxaliplatin treatment. Cancer Lett. 2015;361(1):128–36.PubMedView ArticlePubMed CentralGoogle Scholar
  113. Natsumeda M, Maitani K, Liu Y, Miyahara H, Kaur H, Chu Q, Zhang H, Kahlert UD, Eberhart CG. Targeting notch signaling and autophagy increases cytotoxicity in glioblastoma neurospheres. Brain Pathol. 2016;26(6):713–23.PubMedView ArticlePubMed CentralGoogle Scholar
  114. McBride JD, Rodriguez-Menocal L, Guzman W, Candanedo A, Garcia-Contreras M, Badiavas EV. Bone marrow mesenchymal stem cell-derived CD63+ exosomes transport Wnt3a exteriorly and enhance dermal fibroblast proliferation, migration, and angiogenesis in vitro. Stem Cells Dev. 2017;26(19):1384–98. https://doi.org/10.1089/scd.2017.0087.View ArticlePubMedPubMed CentralGoogle Scholar
  115. Khaksar M, Sayyari M, Rezaie J, Pouyafar A, Montazersaheb S, Rahbarghazi R. High glucose condition limited the angiogenic/cardiogenic capacity of murine cardiac progenitor cells in in vitro and in vivo milieu. Cell Biochem Funct. 2018. https://doi.org/10.1002/cbf.3354.PubMedView ArticlePubMed CentralGoogle Scholar
  116. Wang Y, Li C, Li Y, Zhu Z. Involvement of breast cancer stem cells in tumor angiogenesis. Oncol Lett. 2017;14(6):8150–5. https://doi.org/10.3892/ol.2017.7238.View ArticlePubMedPubMed CentralGoogle Scholar
  117. Xu L, Zhou J, Liu J, Liu Y, Wang L, Jiang R, Diao Z, Yan G, Pèault B, Sun H, Ding L. Different angiogenic potentials of mesenchymal stem cells derived from umbilical artery, umbilical vein, and Wharton's jelly. Stem Cells Int. 2017;2017:3175748. https://doi.org/10.1155/2017/3175748.View ArticlePubMedPubMed CentralGoogle Scholar
  118. Alcayaga-Miranda F, Varas-Godoy M, Khoury M. Harnessing the angiogenic potential of stem cell-derived exosomes for vascular regeneration. Stem Cells Int. 2016;2016:3409169. https://doi.org/10.1155/2016/3409169.View ArticlePubMedPubMed CentralGoogle Scholar
  119. Zhu GQ, Jeon SH, Bae WJ, Choi SW, Jeong HC, Kim KS, Kim SJ, Cho HJ, Ha U, Hong SH. Efficient promotion of autophagy and angiogenesis using mesenchymal stem cell therapy enhanced by the low-energy shock waves in the treatment of erectile dysfunction. Stem Cells Int. 2018;2018. https://doi.org/10.1155/2018/1302672.View ArticleGoogle Scholar
  120. Hassanpour M, Cheraghi O, Siavashi V, Rahbarghazi R, Nouri M. A reversal of age-dependent proliferative capacity of endothelial progenitor cells from different species origin in in vitro condition. J Cardiovasc Thoracic Res. 2016;8(3):102.View ArticleGoogle Scholar
  121. Jiang F. Autophagy in vascular endothelial cells. Clin Exp Pharmacol Physiol. 2016;43(11):1021–8.PubMedView ArticlePubMed CentralGoogle Scholar
  122. Nussenzweig SC, Verma S, Finkel T. The role of autophagy in vascular biology. Circ Res. 2015;116(3):480–8.PubMedPubMed CentralView ArticleGoogle Scholar
  123. Park S, Park M, Park H, Lee K, Kook M, Kim W, Jung J. Nitric oxide-induced autophagy and the activation of activated protein kinase pathway protect against apoptosis in human dental pulp cells. Int Endod J. 2017;50(3):260–70.PubMedView ArticlePubMed CentralGoogle Scholar
  124. Abada A, Elazar Z. Getting ready for building: signaling and autophagosome biogenesis. EMBO Rep. 2014. https://doi.org/10.15252/embr.201439076.PubMedPubMed CentralView ArticleGoogle Scholar
  125. Bharath LP, Mueller R, Li Y, Ruan T, Kunz D, Goodrich R, Mills T, Deeter L, Sargsyan A, Anandh Babu PV. Impairment of autophagy in endothelial cells prevents shear-stress-induced increases in nitric oxide bioavailability. Can J Physiol Pharmacol. 2014;92(7):605–12.PubMedView ArticlePubMed CentralGoogle Scholar
  126. Melero-Martin JM, Dudley AC. Concise review: vascular stem cells and tumor angiogenesis. Stem Cells. 2011;29(2):163–8.PubMedView ArticlePubMed CentralGoogle Scholar
  127. Hassanpour M, Cheraghi O, Brazvan B, Hiradfar A, Aghamohammadzadeh N, Rahbarghazi R, Nouri M. Chronic exposure of human endothelial progenitor cells to diabetic condition abolished the regulated kinetics activity of exosomes. Iran J Pharm Res. 2018;17(3):1068–80.PubMedPubMed CentralGoogle Scholar
  128. Atienzar-Aroca S, Serrano-Heras G, Freire Valls A, Ruiz de Almodovar C, Muriach M, Barcia JM, Garcia-Verdugo JM, Romero FJ, Sancho-Pelluz J. Role of retinal pigment epithelium-derived exosomes and autophagy in new blood vessel formation. J Cell Mol Med. 2018. https://doi.org/10.1111/jcmm.13730.PubMedPubMed CentralView ArticleGoogle Scholar
  129. Torisu T, Torisu K, Lee IH, Liu J, Malide D, Combs CA, Wu XS, Rovira II, Fergusson MM, Weigert R. Autophagy regulates endothelial cell processing, maturation and secretion of von Willebrand factor. Nat Med. 2013;19(10):1281.PubMedPubMed CentralView ArticleGoogle Scholar
  130. Shiroto T, Romero N, Sugiyama T, Sartoretto JL, Kalwa H, Yan Z, Shimokawa H, Michel T. Caveolin-1 is a critical determinant of autophagy, metabolic switching, and oxidative stress in vascular endothelium. PLoS One. 2014;9(2):e87871.PubMedPubMed CentralView ArticleGoogle Scholar
  131. Shan H, Guo D, Li X, Zhao X, Li W, Bai X. From autophagy to senescence and apoptosis in angiotensin II-treated vascular endothelial cells. Apmis. 2014;122(10):985–92.PubMedView ArticlePubMed CentralGoogle Scholar
  132. Rezabakhsh A, Montazersaheb S, Nabat E, Hassanpour M, Montaseri A, Malekinejad H, Movassaghpour AA, Rahbarghazi R, Garjani A. Effect of hydroxychloroquine on oxidative/nitrosative status and angiogenesis in endothelial cells under high glucose condition. BioImpacts: BI. 2017;7(4):219.PubMedView ArticlePubMed CentralGoogle Scholar
  133. Chen F, Chen B, Xiao F-Q, Wu Y-T, Wang R-H, Sun Z-W, Fu G-S, Mou Y, Tao W, Hu X-S. Autophagy protects against senescence and apoptosis via the RAS-mitochondria in high-glucose-induced endothelial cells. Cell Physiol Biochem. 2014;33(4):1058–74.PubMedView ArticlePubMed CentralGoogle Scholar
  134. Kim H-S, Montana V, Jang H-J, Parpura V, J-a K. Epigallocatechin-gallate (EGCG) stimulates autophagy in vascular endothelial cells: a potential role for reducing lipid accumulation. J Biol Chem. 2013;M113:477505.Google Scholar
  135. Chen M-I, Yi L, Jin X, Liang X-y, Zhou Y, Zhang T, Xie Q, Zhou X, Chang H, Y-j F. Resveratrol attenuates vascular endothelial inflammation by inducing autophagy through the cAMP signaling pathway. Autophagy. 2013;9(12):2033–45.PubMedView ArticlePubMed CentralGoogle Scholar
  136. Han J, Pan X-Y, Xu Y, Xiao Y, An Y, Tie L, Pan Y, Li X-J. Curcumin induces autophagy to protect vascular endothelial cell survival from oxidative stress damage. Autophagy. 2012;8(5):812–25.View ArticleGoogle Scholar
  137. Uberti F, Lattuada D, Morsanuto V, Nava U, Bolis G, Vacca G, Squarzanti D, Cisari C, Molinari C. Vitamin D protects human endothelial cells from oxidative stress through the autophagic and survival pathways. J Clin Endocrinol Metab. 2014;99(4):1367–74.PubMedView ArticlePubMed CentralGoogle Scholar
  138. Cadwell K, Liu JY, Brown SL, Miyoshi H, Loh J, Lennerz JK, Kishi C, Kc W, Carrero JA, Hunt S. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature. 2008;456(7219):259.PubMedPubMed CentralView ArticleGoogle Scholar
  139. Ushio H, Ueno T, Kojima Y, Komatsu M, Tanaka S, Yamamoto A, Ichimura Y, Ezaki J, Nishida K, Komazawa-Sakon S. Crucial role for autophagy in degranulation of mast cells. J Allergy Clin Immunol. 2011;127(5):1267–1276. e1266.PubMedView ArticlePubMed CentralGoogle Scholar
  140. Jung HS, Chung KW, Kim JW, Kim J, Komatsu M, Tanaka K, Nguyen YH, Kang TM, Yoon K-H, Kim J-W. Loss of autophagy diminishes pancreatic β cell mass and function with resultant hyperglycemia. Cell Metab. 2008;8(4):318–24.PubMedView ArticlePubMed CentralGoogle Scholar
  141. DeSelm CJ, Miller BC, Zou W, Beatty WL, van Meel E, Takahata Y, Klumperman J, Tooze SA, Teitelbaum SL, Virgin HW. Autophagy proteins regulate the secretory component of osteoclastic bone resorption. Dev Cell. 2011;21(5):966–74.PubMedPubMed CentralView ArticleGoogle Scholar
  142. Pallet N, Sirois I, Bell C, Hanafi LA, Hamelin K, Dieudé M, Rondeau C, Thibault P, Desjardins M, Hebert MJ. A comprehensive characterization of membrane vesicles released by autophagic human endothelial cells. Proteomics. 2013;13(7):1108–20.PubMedView ArticlePubMed CentralGoogle Scholar
  143. Valentijn KM, Sadler JE, Valentijn JA, Voorberg J, Eikenboom J. Functional architecture of Weibel-Palade bodies. Blood:blood-2010-2009. 2011. https://doi.org/10.1182/blood-2010-09-267492.PubMedPubMed CentralView ArticleGoogle Scholar
  144. LaRocca TJ, Henson GD, Thorburn A, Sindler AL, Pierce GL, Seals DR. Translational evidence that impaired autophagy contributes to arterial ageing. J Physiol. 2012;590(14):3305–16.PubMedPubMed CentralView ArticleGoogle Scholar
  145. Rezabakhsh A, Ahmadi M, Khaksar M, Montaseri A, Malekinejad H, Rahbarghazi R, Garjani A. Rapamycin inhibits oxidative/nitrosative stress and enhances angiogenesis in high glucose-treated human umbilical vein endothelial cells: role of autophagy. Biomed Pharmacother. 2017;93:885–94.PubMedView ArticlePubMed CentralGoogle Scholar
  146. Y-l Z, Y-j C, Zhang X, Liu H-h, Tong T, G-d X, Y-p Y, C-f L. The autophagy-lysosome pathway: a novel mechanism involved in the processing of oxidized LDL in human vascular endothelial cells. Biochem Biophys Res Commun. 2010;394(2):377–82.View ArticleGoogle Scholar
  147. Xie Y, You S-J, Zhang Y-L, Han Q, Cao Y-J, Xu X-S, Yang Y-P, Li J, Liu C-F. Protective role of autophagy in AGE-induced early injury of human vascular endothelial cells. Mol Med Rep. 2011;4(3):459–64.PubMedPubMed CentralGoogle Scholar
  148. Chau Y-P, Lin S, Chen J, Tai M. Endostatin induces autophagic cell death in EAhy926 human endothelial cells. Histol Histopathol. 2003;18(3):715–26.PubMedPubMed CentralGoogle Scholar
  149. Kim KW, Paul P, Qiao J, Chung DH. Autophagy mediates paracrine regulation of vascular endothelial cells. Lab Investig. 2013;93(6):639.PubMedView ArticlePubMed CentralGoogle Scholar
  150. Vion A-C, Kheloufi M, Hammoutene A, Poisson J, Lasselin J, Devue C, Pic I, Dupont N, Busse J, Stark K. Autophagy is required for endothelial cell alignment and atheroprotection under physiological blood flow. Proc Natl Acad Sci. 2017;114(41):E8675–84.PubMedView ArticlePubMed CentralGoogle Scholar
  151. Du J, Teng R-J, Guan T, Eis A, Kaul S, Konduri GG, Shi Y. Role of autophagy in angiogenesis in aortic endothelial cells. Am J Phys Cell Phys. 2011;302(2):C383–91.View ArticleGoogle Scholar
  152. Lin A-L, Zheng W, Halloran JJ, Burbank RR, Hussong SA, Hart MJ, Javors M, Shih Y-YI, Muir E, Fonseca RS. Chronic rapamycin restores brain vascular integrity and function through NO synthase activation and improves memory in symptomatic mice modeling Alzheimer’s disease. J Cereb Blood Flow Metab. 2013;33(9):1412–21.PubMedPubMed CentralView ArticleGoogle Scholar
  153. Lesniewski LA, Seals DR, Walker AE, Henson GD, Blimline MW, Trott DW, Bosshardt GC, LaRocca TJ, Lawson BR, Zigler MC. Dietary rapamycin supplementation reverses age-related vascular dysfunction and oxidative stress, while modulating nutrient-sensing, cell cycle, and senescence pathways. Aging Cell. 2017;16(1):17–26.PubMedView ArticlePubMed CentralGoogle Scholar
  154. Li H, Gao A, Feng D, Wang Y, Zhang L, Cui Y, Li B, Wang Z, Chen G. Evaluation of the protective potential of brain microvascular endothelial cell autophagy on blood–brain barrier integrity during experimental cerebral ischemia–reperfusion injury. Transl Stroke Res. 2014;5(5):618–26.PubMedView ArticlePubMed CentralGoogle Scholar
  155. Tang Y, Jacobi A, Vater C, Zou L, Zou X, Stiehler M. Icariin promotes angiogenic differentiation and prevents oxidative stress-induced autophagy in endothelial progenitor cells. Stem Cells. 2015;33(6):1863–77.PubMedView ArticlePubMed CentralGoogle Scholar
  156. Zheng Y, Wu Z, Yi F, Orange M, Yao M, Yang B, Liu J, Zhu H. By activating Akt/eNOS Bilobalide B inhibits autophagy and promotes angiogenesis following focal cerebral ischemia reperfusion. Cell Physiol Biochem. 2018;47(2):604–16.PubMedView ArticlePubMed CentralGoogle Scholar
  157. Selvakumaran M, Amaravadi RK, Vasilevskaya IA, O'Dwyer PJ. Autophagy inhibition sensitizes colon cancer cells to antiangiogenic and cytotoxic therapy. Clin Cancer Res. 2013. https://doi.org/10.1158/1078-0432.CCR-12-1542.PubMedView ArticlePubMed CentralGoogle Scholar
  158. Zhou W, Hao M, Du X, Chen K, Wang G, Yang J. Advances in targeted therapy for osteosarcoma. Discov Med. 2014;17(96):301–7.PubMedPubMed CentralGoogle Scholar
  159. Hu Y-L, DeLay M, Jahangiri A, Molinaro AM, Rose SD, Carbonell WS, Aghi MK. Hypoxia-induced autophagy promotes tumor cell survival and adaptation to antiangiogenic treatment in glioblastoma. Cancer Res. 2012. https://doi.org/10.1158/0008-5472.CAN-11-3831.PubMedPubMed CentralView ArticleGoogle Scholar
  160. Jiang L, Yin M, Wei X, Liu J, Wang X, Niu C, Kang X, Xu J, Zhou Z, Sun S. Bach1 represses Wnt/β-catenin signaling and angiogenesis. Circ Res:CIRCRESAHA. 2015;115:306829.Google Scholar
  161. Li X, Lu Q, Xie W, Wang Y, Wang G. Anti-tumor effects of triptolide on angiogenesis and cell apoptosis in osteosarcoma cells by inducing autophagy via repressing Wnt/β-catenin signaling. Biochem Biophys Res Commun. 2018;496(2):443–9.PubMedView ArticlePubMed CentralGoogle Scholar
  162. Kumar S, Guru S, Pathania A, Kumar A, Bhushan S, Malik F. Autophagy triggered by magnolol derivative negatively regulates angiogenesis. Cell Death Dis. 2013;4(10):e889.PubMedPubMed CentralView ArticleGoogle Scholar
  163. Liu H, Yu S, Zhang H, Xu J. Angiogenesis impairment in diabetes: role of methylglyoxal-induced receptor for advanced glycation endproducts, autophagy and vascular endothelial growth factor receptor 2. PLoS One. 2012;7(10):e46720.PubMedPubMed CentralView ArticleGoogle Scholar
  164. Torres A, Gubbiotti MA, Iozzo RV. Decorin-inducible Peg3 evokes beclin 1-mediated autophagy and thrombospondin 1-mediated angiostasis. J Biol Chem:jbc. 2017;M116:753632.Google Scholar
  165. Kim KW, Paul P, Qiao J, Lee S, Chung DH. Enhanced autophagy blocks angiogenesis via degradation of gastrin-releasing peptide in neuroblastoma cells. Autophagy. 2013;9(10):1579–90.PubMedPubMed CentralView ArticleGoogle Scholar
  166. Abdel-Aziz AK, Shouman S, El-Demerdash E, Elgendy M, Abdel-Naim AB. Chloroquine synergizes sunitinib cytotoxicity via modulating autophagic, apoptotic and angiogenic machineries. Chem Biol Interact. 2014;217:28–40.PubMedView ArticlePubMed CentralGoogle Scholar
  167. Du J-H, Li X, Li R, Cheng B-X, Kuerbanjiang M, Ma L. Role of autophagy in angiogenesis induced by a high-glucose condition in RF/6A cells. Ophthalmologica. 2017;237(2):85–95.PubMedView ArticlePubMed CentralGoogle Scholar
  168. Li R, Du J, Chang Y. Role of autophagy in hypoxia-induced angiogenesis of RF/6A cells in vitro. Curr Eye Res. 2016;41(12):1566–70.PubMedView ArticlePubMed CentralGoogle Scholar
  169. Du J, Li R, Yang L, Ma R, Zhu X, Ma L. The role of autophagy in chemerin-induced angiogenesis of RF/6A cells. Int J Clin Exp Med. 2016;9(9):17802–11.Google Scholar
  170. Nguyen TMB, Subramanian IV, Xiao X, Ghosh G, Nguyen P, Kelekar A, Ramakrishnan S. Endostatin induces autophagy in endothelial cells by modulating Beclin 1 and β-catenin levels. J Cell Mol Med. 2009;13(9b):3687–98.PubMedPubMed CentralView ArticleGoogle Scholar
  171. Lu Q, Yao Y, Hu Z, Hu C, Song Q, Ye J, Xu C, Wang AZ, Chen Q, Wang QK. Angiogenic factor AGGF1 activates autophagy with an essential role in therapeutic angiogenesis for heart disease. PLoS Biol. 2016;14(8):e1002529.PubMedPubMed CentralView ArticleGoogle Scholar
  172. Niu J, Wang K, Zhelyabovska O, Saad Y, Kolattukudy PE. MCP-1-induced protein promotes endothelial-like and angiogenic properties in human bone marrow monocytic cells. J Pharmacol Exp Ther. 2013;347(2):288–97.PubMedPubMed CentralView ArticleGoogle Scholar
  173. Kim K-A, Shin D, Kim J-H, Shin Y-J, Rajanikant G, Majid A, Baek S-H, Bae O-N. Role of autophagy in endothelial damage and blood–brain barrier disruption in ischemic stroke. Stroke. 2018;49(6):1571–9.PubMedView ArticlePubMed CentralGoogle Scholar
  174. Sharma A, Wu SM. Autophagy-the friendly fire in endothelial cell regeneration. Focus on “autophagy in endothelial progenitor cells is cytoprotective in hypoxic conditions”. Am J Phys Cell Phys. 2013;304(7):C614–6.View ArticleGoogle Scholar
  175. Chen W, Wu Y, Li L, Yang M, Shen L, Liu G, Tan J, Zeng W, Zhu C. Adenosine accelerates the healing of diabetic ischemic ulcers by improving autophagy of endothelial progenitor cells grown on a biomaterial. Sci Rep. 2015;5:11594.PubMedPubMed CentralView ArticleGoogle Scholar
  176. Zhi K, Li M, Bai J, Wu Y, Zhou S, Zhang X, Qu L. Quercitrin treatment protects endothelial progenitor cells from oxidative damage via inducing autophagy through extracellular signal-regulated kinase. Angiogenesis. 2016;19(3):311–24.PubMedView ArticlePubMed CentralGoogle Scholar
  177. Dai X, Zeng J, Yan X, Lin Q, Wang K, Chen J, Shen F, Gu X, Wang Y, Chen J. Sitagliptin-mediated preservation of endothelial progenitor cell function via augmenting autophagy enhances ischaemic angiogenesis in diabetes. J Cell Mol Med. 2018;22(1):89–100.PubMedView ArticlePubMed CentralGoogle Scholar
  178. Flammer AJ, Anderson T, Celermajer DS, Creager MA, Deanfield J, Ganz P, Hamburg NM, Lüscher TF, Shechter M, Taddei S. The assessment of endothelial function: from research into clinical practice. Circulation. 2012;126(6):753–67.PubMedPubMed CentralView ArticleGoogle Scholar
  179. Wang C, Mao C, Lou Y, Xu J, Wang Q, Zhang Z, Tang Q, Zhang X, Xu H, Feng Y. Monotropein promotes angiogenesis and inhibits oxidative stress-induced autophagy in endothelial progenitor cells to accelerate wound healing. J Cell Mol Med. 2018;22(3):1583–600.PubMedView ArticlePubMed CentralGoogle Scholar
  180. Rahbarghazi R, Nassiri SM, Khazraiinia P, Kajbafzadeh A-M, Ahmadi SH, Mohammadi E, Molazem M, Zamani-Ahmadmahmudi M. Juxtacrine and paracrine interactions of rat marrow-derived mesenchymal stem cells, muscle-derived satellite cells, and neonatal cardiomyocytes with endothelial cells in angiogenesis dynamics. Stem Cells Dev. 2012;22(6):855–65.PubMedPubMed CentralView ArticleGoogle Scholar
  181. An Y, Liu W, Xue P, Ma Y, Zhang L, Zhu B, Qi M, Li L, Zhang Y, Wang Q. Autophagy promotes MSC-mediated vascularization in cutaneous wound healing via regulation of VEGF secretion. Cell Death Dis. 2018;9(2):58.PubMedPubMed CentralView ArticleGoogle Scholar
  182. Wei W, An Y, An Y, Fei D, Wang Q. Activation of autophagy in periodontal ligament mesenchymal stem cells promotes angiogenesis in periodontitis. J Periodontol. 2018.Google Scholar
  183. Kim K-A, Shin Y-J, Akram M, Kim E-S, Choi K-W, Suh H, Lee C-H, Bae O-N. High glucose condition induces autophagy in endothelial progenitor cells contributing to angiogenic impairment. Biol Pharm Bull. 2014;37(7):1248–52.PubMedView ArticlePubMed CentralGoogle Scholar
  184. Wang H-J, Zhang D, Tan Y-Z, Li T. Autophagy in endothelial progenitor cells is cytoprotective in hypoxic conditions. Am J Phys Cell Phys. 2012;304(7):C617–26.View ArticleGoogle Scholar

Copyright

© The Author(s). 2018

Advertisement